Nonalcoholic fatty liver disease

NAFLD

non-alcoholic fatty liver disease: A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K76.0 Cause of death: ICD-10 — K76.0 2 out of 7 registries used, show all original rules.	3649
4. Check minimum number of events None	3649
5. Include endpoints None	3649
6. Filter based on genotype QC (FinnGen only)	3649

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K76
Name in latin: Degeneratio adiposa hepatis non alibi classificata

NAME	NAFLD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K760
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K760
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Nonalcoholic fatty liver disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	18945	9005	9846
Only index persons	18156	8715	9441
Unadjusted period prevalence (%)
Whole population	0.27	0.26	0.28
Only index persons	0.34	0.32	0.36
Median age at first event (years)
Whole population	52.61	56.47	49.12
Only index persons	52.46	56.38	48.84

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3649	2071	1578
Unadjusted period prevalence (%)	0.70	0.71	0.70
Median age at first event (years)	54.84	55.87	53.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3146: Matched controls
31459

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A10BA02

ATC

metformin; oral

4.8

323.0

1459

4805

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4503599627370496.0

323.0

3145

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

5.1

314.4

1262

3671

103

Kela drug reimbursment

Diabetes, insulin-treated

4.4

281.7

1371

4730

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.4

278.8

1334

4518

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

21.8

257.6

387

201

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

6.5

255.0

742

1418

T90

ICPC

Diabetes non-insulin dependent

4.3

249.7

1196

3961

K76.9

ICD-10 Finland

Liver disease, unspecified

23.2

192.1

282

133

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.2

185.7

829

2455

E66.00

ICD-10 Finland

Metabolic syndrome

6.8

177.2

483

814

E66.01

ICD-10 Finland

Obesity due to excess calories

5.4

175.2

583

1264

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.2

175.2

1264

5477

I10

ICD-10 Finland

Essential (primary) hypertension

2.8

159.6

1965

11781

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

15.3

149.0

254

180

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

6.5

144.7

406

702

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

23.8

134.5

195

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

34.2

133.2

175

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

6.2

122.4

352

623

A10BH01

ATC

sitagliptin; oral

4.3

122.4

504

1331

E66.8

ICD-10 Finland

Other obesity

5.4

117.3

380

777

A10BK03

ATC

empagliflozin; oral

4.6

112.5

430

1050

G47.3

ICD-10 Finland

Sleep apnoea

2.7

111.0

949

4306

SPAT1262

SPAT

Handing over of treatment supplies

3.0

108.5

766

3076

A02BC02

ATC

pantoprazole; systemic

2.3

102.6

2186

15592

A10BJ06

ATC

semaglutide; parenteral

6.9

101.4

266

413

A10AE04

ATC

insulin glargine; parenteral

3.8

101.1

485

1453

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

47.3

100.5

123

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.5

95.5

977

4830

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.9

93.1

429

1236

N02AX02

ATC

tramadol; systemic, rectal

2.2

90.6

1495

9249

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

88.7

584

2204

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

15.5

81.7

137

C08CA01

ATC

amlodipine; oral

2.2

80.1

1125

6375

UJF32

NOMESCO Finland

Coloscopy

2.3

78.4

913

4728

205

Kela drug reimbursment

Chronic hypertension

2.3

76.9

850

4284

C07AB07

ATC

bisoprolol; oral

2.1

76.8

1412

8932

C03CA01

ATC

furosemide; systemic

2.4

75.8

785

3822

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.9

73.0

495

1882

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

72.2

1226

7447

R03AC02

ATC

salbutamol; inhalant

1.9

69.4

1753

12357

H02AB06

ATC

prednisolone; systemic

1.9

68.3

1531

10295

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

67.9

1368

8829

A10BG03

ATC

pioglitazone; oral

6.9

66.0

171

259

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.4

64.7

348

1121

A10BK01

ATC

dapagliflozin; oral

4.4

64.4

250

608

A10BJ02

ATC

liraglutide; parenteral

6.3

63.8

177

294

C03DA01

ATC

spironolactone; oral

3.1

62.6

379

1327

E66.9

ICD-10 Finland

Obesity, unspecified

5.0

60.6

207

441

A10BB12

ATC

glimepiride; oral

3.9

60.1

263

714

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

59.4

620

2982

R94.5

ICD-10 Finland

Abnormal results of liver function studies

10.6

58.5

116

113

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.6

55.7

448

1871

R5140

NOMESCO Finland

Monitoring the use of the aid

2.6

52.7

426

1779

M04AA01

ATC

allopurinol; systemic

2.7

50.9

394

1601

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

13.9

50.6

T82

ICPC

Obesity

4.3

50.5

200

494

A02BC05

ATC

esomeprazole; systemic

1.8

49.8

1314

9003

C10AA01

ATC

simvastatin; oral

1.8

49.1

1179

7819

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

48.6

468

2141

XCK10

NOMESCO Finland

Photography of fundus of eye

2.7

48.1

365

1465

A10AE05

ATC

insulin detemir; parenteral

3.5

47.8

242

739

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.2

47.5

188

464

R06.0

ICD-10 Finland

Dyspnoea

2.0

46.7

760

4380

C10AA05

ATC

atorvastatin; oral

1.8

46.6

1114

7347

N03AX16

ATC

pregabalin; oral

1.9

46.3

785

4588

WX110

NOMESCO Finland

Local anesthesy

1.8

45.7

2185

17750

M25.5

ICD-10 Finland

Pain in joint

1.8

45.5

948

5956

160

Kela drug reimbursment

exenatide

5.7

45.4

136

249

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

44.2

581

3063

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.3

44.1

454

2142

N02BE01

ATC

paracetamol; systemic, rectal

1.9

44.0

2647

23013

N06AX16

ATC

venlafaxine; oral

2.2

43.9

529

2685

M79.6

ICD-10 Finland

Pain in limb

1.8

43.0

1122

7557

E66

ICD-10 Finland

Obesity

3.6

42.9

207

608

C09AA02

ATC

enalapril; systemic

2.1

42.8

556

2914

A10BH05

ATC

linagliptin; oral

3.8

42.5

187

508

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.0

42.5

605

3292

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.2

41.2

455

2213

J01DB01

ATC

cefalexin; oral

1.8

41.1

2554

22050

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.3

40.2

402

1862

UJF30

NOMESCO Finland

Ileoscopy through colon

2.5

39.9

354

1544

C09CA01

ATC

losartan; oral

1.9

39.4

710

4208

N05AH04

ATC

quetiapine; oral

2.0

37.7

549

2996

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

37.7

356

1602

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.8

37.5

130

281

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

37.4

800

5012

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

37.0

686

4091

A10BD07

ATC

metformin and sitagliptin; systemic

3.4

36.9

188

576

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.2

36.9

129

R4110

NOMESCO Finland

Physiotherapy

1.8

36.6

827

5264

L04AX01

ATC

azathioprine; systemic

3.2

36.5

201

652

J01FF01

ATC

clindamycin; systemic

1.8

36.4

867

5610

M54.5

ICD-10 Finland

Low back pain

1.7

36.3

1012

6863

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

36.2

1436

10731

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

36.1

265

1038

N06AX11

ATC

mirtazapine; oral

1.7

35.8

984

6640

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

35.8

403

1971

J01MA12

ATC

levofloxacin; systemic

2.0

35.6

557

3120

A02BC03

ATC

lansoprazole; oral

1.7

35.6

884

5784

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.7

35.5

262

1030

N03AX12

ATC

gabapentin; oral

2.0

35.5

507

2742

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

35.4

714

4375

H02AB07

ATC

prednisone; oral

2.1

35.1

451

2336

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

35.0

641

3797

H03AA01

ATC

levothyroxine sodium; systemic

1.8

34.8

720

4442

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

34.7

702

4300

N06AB04

ATC

citalopram; systemic

1.8

34.7

675

4082

WX002

NOMESCO Finland

Sedation and analgesia

1.9

34.7

605

3525

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.1

34.6

206

706

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

23.7

34.4

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

34.4

531

2954

J01MA02

ATC

ciprofloxacin; systemic

1.6

34.2

1124

7950

P01AB01

ATC

metronidazole; oral, rectal

1.6

34.2

1219

8810

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.2

33.9

132

321

J01AA02

ATC

doxycycline; systemic

1.7

33.9

2381

20467

C10AA07

ATC

rosuvastatin; oral

1.8

33.4

710

4413

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

33.3

370

1795

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

33.2

1335

9934

N05CF01

ATC

zopiclone; oral

1.7

33.1

907

6084

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

33.0

908

6098

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

32.7

198

686

A05AA02

ATC

ursodeoxycholic acid; oral

5.6

32.6

177

M01AH05

ATC

etoricoxib; oral

1.6

32.6

1855

15013

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

32.5

347

1654

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

31.4

1246

9197

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

31.3

279

1216

A10BJ05

ATC

dulaglutide; parenteral

8.5

31.2

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

6.5

31.0

129

D97

ICPC

Liver disease NOS

12.4

31.0

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

30.5

888

6031

E83.1

ICD-10 Finland

Disorders of iron metabolism

13.5

30.4

A02BC01

ATC

omeprazole; systemic

1.7

30.0

785

5168

C09DA01

ATC

losartan and diuretics; oral

2.2

30.0

326

1563

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.3

30.0

296

1355

A10BX07

ATC

[U] liraglutide; parenteral

6.0

29.9

143

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

29.9

505

2892

J01DA01

ATC

[U] cefalexin; systemic

1.5

29.9

1888

15501

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

29.8

485

2740

C08CA13

ATC

lercanidipine; oral

2.1

29.6

373

1906

N06AB10

ATC

escitalopram; oral

1.8

29.6

642

3994

N06AX21

ATC

duloxetine; oral

2.1

29.5

366

1858

R11

ICD-10 Finland

Nausea and vomiting

2.5

29.4

247

1042

R06AE07

ATC

cetirizine; oral

1.6

29.4

1334

10125

K74.0

ICD-10 Finland

Hepatic fibrosis

50.5

29.4

D07AC01

ATC

betamethasone; topical

1.6

29.4

1003

7095

N05BA04

ATC

oxazepam; oral

1.7

29.2

727

4716

A07EC02

ATC

mesalazine; oral, rectal

2.6

29.1

219

870

C09AA05

ATC

ramipril; oral

1.8

29.0

631

3928

J01FA06

ATC

roxithromycin; oral

1.6

28.9

1215

9043

M10.9

ICD-10 Finland

Gout, unspecified

2.8

28.9

196

732

A07EA06

ATC

budesonide; oral, local oral

3.3

28.4

148

462

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

28.3

519

3054

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

28.1

223

911

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

28.1

1705

13774

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.1

28.1

184

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

27.9

764

5080

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

27.9

358

1843

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

5.1

27.5

180

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

27.4

473

2722

S18

ICPC

Laceration/cut

1.5

27.1

1190

8904

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

27.1

312

1534

R18

ICD-10 Finland

Ascites

5.2

26.9

167

SPAT1263

SPAT

Sampling

1.5

26.8

1206

9069

B01AB05

ATC

enoxaparin; parenteral

1.6

26.8

835

5743

K29.7

ICD-10 Finland

Gastritis, unspecified

3.5

26.5

130

387

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.9

26.4

172

624

162

Kela drug reimbursment

liraglutide

6.0

26.4

126

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

26.4

452

2590

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

26.3

1242

9435

K02.1

ICD-10 Finland

Caries of dentine

1.5

26.2

1738

14216

L17

ICPC

Foot/toe symptom/complaint

1.7

26.2

707

4670

C03AA03

ATC

hydrochlorothiazide; oral

2.3

26.0

265

1230

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

26.0

666

4334

A46

ICD-10 Finland

Erysipelas

2.0

25.8

384

2092

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

25.7

350

1839

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

25.6

789

5399

K70.0

ICD-10 Finland

Alcoholic fatty liver

8.3

25.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

25.4

1549

12412

R60.0

ICD-10 Finland

Localized oedema

2.1

25.2

303

1514

A06AD11

ATC

lactulose; oral

2.0

25.1

354

1889

R4190

NOMESCO Finland

Nutritional therapy

3.2

25.1

134

426

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

25.0

284

1386

WX290

NOMESCO Finland

Other blockade of nerve

1.5

24.9

1373

10747

D07AC13

ATC

mometasone; topical

1.6

24.7

844

5919

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

24.5

247

1141

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

24.4

200

832

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

24.4

793

5487

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

24.4

1758

14534

M79.1

ICD-10 Finland

Myalgia

1.9

24.3

394

2213

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

24.3

788

5451

R01AD09

ATC

mometasone; nasal

1.5

24.1

1358

10648

WX722

NOMESCO Finland

PEEP

2.7

23.9

166

629

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

23.8

505

3101

J01FA09

ATC

clarithromycin; systemic

1.5

23.7

971

7092

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

23.7

518

3205

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

23.7

455

2706

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.0

23.6

142

491

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

10.4

23.5

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

23.4

177

702

R06.5

ICD-10 Finland

Mouth breathing

2.1

23.4

300

1538

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

23.3

320

1685

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.5

23.3

191

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

23.2

1070

8020

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

9.4

23.2

C10AB05

ATC

fenofibrate; oral

4.6

23.2

183

N06AX03

ATC

mianserin; oral

2.7

23.2

165

633

R03BA02

ATC

budesonide; inhalant

1.7

23.1

519

3240

J20

ICD-10 Finland

Acute bronchitis

2.0

22.9

293

1502

M01AE02

ATC

naproxen; oral, rectal

1.5

22.7

1683

13893

E0000UV

ATC

1.5

22.7

1123

8536

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

22.6

358

1990

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

6.4

22.3

K30

ICD-10 Finland

Functional dyspepsia

2.0

22.2

315

1681

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.7

22.1

100

280

JJA20

NOMESCO Finland

Open biopsy of liver

14.4

22.1

L16

ICPC

Ankle symptom/complaint

2.0

22.1

299

1569

N03AX09

ATC

lamotrigine; oral

2.5

22.0

173

705

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

21.9

308

1638

N06AA09

ATC

amitriptyline; systemic

2.0

21.9

308

1638

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

21.9

2130

18497

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.6

21.7

168

R05FB02

ATC

cough suppressants and expectorants

1.5

21.7

1058

7998

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

21.5

1103

8422

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

21.3

238

1152

R52.9

ICD-10 Finland

Pain, unspecified

2.1

21.3

248

1220

M03BX02

ATC

tizanidine; oral

1.4

21.2

1901

16190

P06

ICPC

Sleep disturbance

2.0

21.2

300

1600

C10AC01

ATC

colestyramine; oral

3.3

21.1

108

334

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

20.9

366

2104

R42

ICD-10 Finland

Dizziness and giddiness

1.7

20.9

545

3537

A02BA02

ATC

ranitidine; systemic

1.7

20.9

530

3414

R50.9

ICD-10 Finland

Fever, unspecified

1.8

20.9

392

2308

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

20.8

568

3734

K74.3

ICD-10 Finland

Primary biliary cirrhosis

7.9

20.7

UJD02

NOMESCO Finland

Gastroscopy

2.6

20.7

152

596

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

11.6

20.7

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

20.7

842

6106

R53

ICD-10 Finland

Malaise and fatigue

1.7

20.6

524

3381

J01CA04

ATC

amoxicillin; systemic

1.5

20.6

2417

21653

L28

ICPC

Limited function/disability (L)

1.8

20.2

372

2177

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

20.2

342

1945

K76.89

ICD-10 Finland

Other specified diseases of liver

13.1

20.1

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

20.1

133

490

N06AB03

ATC

fluoxetine; oral

1.8

20.0

391

2328

L04AB04

ATC

adalimumab; parenteral

3.6

20.0

257

WX892

NOMESCO Finland

Monitored bed care

2.2

20.0

223

1077

J01FA10

ATC

azithromycin; systemic

1.4

19.9

1741

14661

C10AX09

ATC

ezetimibe; oral

1.9

19.9

307

1688

M79.7

ICD-10 Finland

Fibromyalgia

2.9

19.9

125

445

ZX120

NOMESCO Finland

Intravenous

2.0

19.9

280

1489

R03AC03

ATC

terbutaline; inhalant

1.7

19.8

411

2495

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

19.8

240

1204

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.2

19.8

219

1054

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

19.7

780

5612

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

19.6

2063

17961

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

10.4

19.6

M01AB05

ATC

diclofenac; systemic, rectal

1.4

19.5

1997

17289

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

19.5

261

1361

C09BA02

ATC

enalapril and diuretics; systemic

2.2

19.5

215

1033

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

19.5

1560

12907

L03

ICPC

Low back symptom/complaint

1.6

19.4

666

4629

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

19.4

1914

16443

R02

ICPC

Shortness of breath/dyspnoea

1.9

19.4

325

1841

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

19.4

272

1444

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

19.4

188

854

H02AB04

ATC

methylprednisolone; systemic

1.7

19.3

418

2569

A10BH02

ATC

vildagliptin; oral

4.2

19.2

176

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

11.0

19.2

K70.1

ICD-10 Finland

Alcoholic hepatitis

7.5

19.1

K92.0

ICD-10 Finland

Haematemesis

3.7

19.1

226

R05

ICPC

Cough

1.6

19.0

605

4127

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.3

19.0

295

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

19.0

225

1116

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.8

18.9

122

443

R07.3

ICD-10 Finland

Other chest pain

2.0

18.9

270

1444

AA1AD

NOMESCO Finland

CT of head and brain

1.6

18.8

589

4001

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

18.8

210

1013

K50.0

ICD-10 Finland

Crohn disease of small intestine

4.2

18.8

175

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

18.8

712

5063

N05AX12

ATC

aripiprazole; systemic

2.6

18.7

139

548

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

18.6

469

3011

K72.9

ICD-10 Finland

Hepatic failure, unspecified

9.4

18.6

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

18.5

345

2023

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

18.5

1079

8391

R51.80

ICD-10 Finland

Headache

1.7

18.3

429

2696

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

18.2

792

5799

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

18.0

1440

11843

A10BX04

ATC

[U] exenatide; parenteral

5.2

18.0

110

R05

ICD-10 Finland

Cough

1.6

17.9

518

3442

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

17.9

272

1484

R03BA05

ATC

fluticasone; inhalant

1.6

17.9

512

3396

XG466

NOMESCO Finland

Sleep oxymetry

2.9

17.9

113

404

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

17.8

531

3559

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

17.8

313

1799

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.9

17.7

195

K51.5

ICD-10 Finland

Left sided colitis

2.9

17.7

110

391

A10BX09

ATC

[U] dapagliflozin; oral

5.8

17.6

N05BA12

ATC

alprazolam; oral

1.8

17.6

303

1729

L08

ICPC

Shoulder symptom/complaint

1.6

17.6

522

3494

C07AB02

ATC

metoprolol; systemic

1.6

17.5

470

3063

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.5

17.5

243

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

17.5

108

382

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.5

17.4

144

603

N30.0

ICD-10 Finland

Acute cystitis

1.8

17.4

346

2068

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

17.4

670

4770

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

17.4

477

3128

N06AB06

ATC

sertraline; oral

1.8

17.2

315

1837

C07AA05

ATC

propranolol; systemic

1.6

17.2

554

3782

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.9

17.1

186

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.1

17.1

302

N02AA05

ATC

oxycodone; systemic

1.7

17.1

345

2070

K83.0

ICD-10 Finland

Cholangitis

4.5

17.0

135

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

17.0

537

3648

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

16.9

281

1586

UJF92

NOMESCO Finland

Capsular endoscopy

3.4

16.9

245

EBA00

NOMESCO Finland

Extraction of tooth

1.4

16.9

922

7048

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

16.9

421

2691

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

16.8

205

1029

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.5

16.8

136

563

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

16.7

249

1349

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.1

16.7

193

947

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

16.7

800

5955

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

16.6

214

1100

R01AD08

ATC

fluticasone; nasal

1.5

16.6

820

6144

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

16.6

563

3891

D05AX52

ATC

calcipotriol, combinations; topical

2.1

16.6

187

907

H01

ICPC

Ear pain/earache

1.8

16.5

290

1666

RD210

NOMESCO Finland

3.6

16.5

213

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

16.5

378

2359

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

16.4

245

1331

A07AA11

ATC

rifaximin; oral

23.2

16.4

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

16.4

1268

10309

D07XC01

ATC

betamethasone, combinations; topical

1.7

16.4

335

2018

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.8

16.3

104

374

M02AA07

ATC

piroxicam; topical

1.4

16.1

977

7600

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

16.1

298

1741

WX320

NOMESCO Finland

Spinalanesthesy

1.5

16.0

585

4109

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

15.9

309

1831

R74

ICPC

Upper respiratory infection acute

1.4

15.9

786

5879

Z01.2

ICD-10 Finland

Dental examination

1.4

15.8

1179

9510

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.8

15.8

273

1560

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

15.7

209

1087

N06AX12

ATC

bupropion; oral

2.0

15.7

199

1018

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

15.6

505

3442

K50.8

ICD-10 Finland

Other Crohn disease

3.6

15.6

197

K92.1

ICD-10 Finland

Melaena

2.4

15.6

132

560

C10AA04

ATC

fluvastatin; oral

2.0

15.5

195

993

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

15.4

197

1008

M10

ICD-10 Finland

Gout

2.5

15.4

118

475

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

15.4

221

1184

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

15.4

253

1421

WX780

NOMESCO Finland

Remote monitoring CPAP

2.3

15.4

139

610

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.7

15.4

108

415

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.0

15.3

309

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

15.3

174

850

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

15.2

282

1646

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.1

15.2

277

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.0

15.2

193

985

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.1

15.2

142

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

15.2

704

5194

SPAT1240

SPAT

Therapeutic discussion

1.7

15.2

304

1822

A28

ICPC

Limited function/disability NOS

1.7

15.1

299

1784

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

15.1

906

7020

D11

ICPC

Diarrhoea

1.7

15.1

308

1855

OAB72

NOMESCO Finland

Weight control and weight loss guidance

6.6

15.1

N05CD07

ATC

temazepam; oral

1.7

15.0

303

1819

A10AE06

ATC

insulin degludec; parenteral

2.6

14.9

108

421

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

14.9

134

589

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

14.8

571

4049

P01

ICPC

Feeling anxious/nervous/tense

1.8

14.8

268

1556

ZXA00

NOMESCO Finland

Right side

1.5

14.7

685

5050

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

14.7

681

5019

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

14.7

579

4128

D07AD01

ATC

clobetasol; topical

1.6

14.7

434

2894

J02AC01

ATC

fluconazole; systemic

1.4

14.7

1115

8992

K75.4

ICD-10 Finland

Autoimmune hepatitis

21.1

14.6

WX723

NOMESCO Finland

CPAP therapy

2.4

14.6

125

533

P76

ICPC

Depressive disorder

2.0

14.6

186

952

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

14.5

264

1532

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

14.5

419

2774

M01AX17

ATC

nimesulide; oral

1.5

14.5

644

4705

D01

ICPC

Abdominal pain/cramps general

1.8

14.5

284

1687

A02BA04

ATC

nizatidine; systemic

1.9

14.4

201

1064

C09CA06

ATC

candesartan; oral

1.5

14.4

585

4194

C07AG02

ATC

carvedilol; oral

2.2

14.3

150

704

L15

ICPC

Knee symptom/complaint

1.5

14.3

544

3843

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

14.3

333

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

17.0

14.3

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.9

14.3

290

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

14.2

231

1293

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

14.2

469

3207

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.2

14.2

149

702

K07

ICPC

Swollen ankles/oedema

2.6

14.2

107

428

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

14.1

307

1886

C08CA02

ATC

felodipine; oral

1.9

14.1

208

1124

C09CA03

ATC

valsartan; oral

1.8

14.0

229

1282

S97

ICPC

Chronic ulcer skin

2.3

14.0

134

606

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

14.0

337

2129

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

14.0

313

1937

R06AX13

ATC

loratadine; oral

1.6

14.0

427

2867

N06AA12

ATC

doxepin; systemic

2.1

14.0

153

736

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

14.0

471

3239

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

14.0

486

3365

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

13.8

409

2722

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

13.8

504

3526

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

13.8

238

1359

R4120

NOMESCO Finland

Occupational therapy

2.0

13.8

186

971

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

13.8

276

1651

A99

ICPC

Disease/condition unspecnature/site

1.9

13.8

202

1089

S29

ICPC

Skin symptom/complaint other

1.6

13.7

411

2744

A01

ICPC

Pain general/multiple sites

1.9

13.7

202

1093

M48.0

ICD-10 Finland

Spinal stenosis

1.7

13.7

284

1718

I11

ICD-10 Finland

Hypertensive heart disease

9.1

13.7

D02

ICPC

Abdominal pain epigastric

2.1

13.7

164

818

A07EA02

ATC

hydrocortisone; rectal

2.9

13.7

287

SPAT1281

SPAT

Other administrative function

1.9

13.7

215

1191

XF402

NOMESCO Finland

ECG with work load test

1.7

13.6

285

1729

SPAT1254

SPAT

Administration of medicine

1.6

13.5

346

2219

C07BB07

ATC

bisoprolol and thiazides; systemic

2.4

13.5

113

478

Z71.8

ICD-10 Finland

Other specified counselling

1.4

13.5

639

4719

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

3.8

13.5

149

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

5.3

13.4

SPAT1104

SPAT

Monitoring of emergency patient

2.0

13.4

173

889

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.7

13.4

349

E87.6

ICD-10 Finland

Hypokalaemia

2.7

13.4

341

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.3

13.4

116

L04AB01

ATC

etanercept; parenteral

3.6

13.4

165

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.7

13.4

267

1595

K72.1

ICD-10 Finland

Chronic hepatic failure

18.3

13.4

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.6

13.3

393

L12

ICPC

Hand/finger symptom/complaint

1.6

13.2

369

2422

G44.2

ICD-10 Finland

Tension-type headache

1.6

13.1

359

2344

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

13.1

221

WX402

NOMESCO Finland

General anaesthesia

1.5

13.0

476

3328

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.7

13.0

327

S10

ICPC

Boil/carbuncle

2.1

12.9

148

726

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

12.9

353

2305

N05CF02

ATC

zolpidem; oral

1.5

12.9

490

3457

E66.0

ICD-10 Finland

Obesity due to excess calories

4.4

12.8

103

L01BB02

ATC

mercaptopurine; oral

4.1

12.7

117

N05AA02

ATC

levomepromazine; systemic

2.2

12.7

127

587

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

9.0

12.7

SPAT1310

SPAT

Counselling related to known health issue

1.4

12.7

823

6426

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

12.7

317

2019

R03BB04

ATC

tiotropium bromide; inhalant

1.8

12.6

228

1321

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.5

12.6

399

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

12.6

199

1103

SPAT1054

SPAT

Examination of peripheral nervous system

3.3

12.6

195

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.8

12.6

143

E000003

ATC

2.2

12.5

130

610

R03DC03

ATC

montelukast; oral

1.5

12.5

434

3000

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

12.5

259

1568

SPAT1255

SPAT

Intravenous administration of medicine

1.9

12.5

176

938

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

2.9

12.5

274

E03

ICD-10 Finland

Other hypothyroidism

2.0

12.4

159

814

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

12.4

354

2333

N05AH03

ATC

olanzapine; systemic

1.9

12.4

175

933

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.8

12.3

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

12.3

220

1270

UKC02

NOMESCO Finland

Cystoscopy

1.6

12.3

347

2281

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

12.3

141

693

D07AA02

ATC

hydrocortisone; topical

1.6

12.3

354

2339

K57

ICD-10 Finland

Diverticular disease of intestine

3.1

12.3

210

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

6.2

12.3

Z94.4

ICD-10 Finland

Liver transplant status

9.0

12.2

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.6

12.1

329

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.1

12.1

218

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

12.1

689

5254

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.6

12.0

329

2146

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

12.0

369

2476

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

12.0

572

4219

A11

ICPC

Chest pain NOS

1.9

12.0

184

1011

Z01.7

ICD-10 Finland

Laboratory examination

1.6

12.0

290

1833

SPAT1312

SPAT

General health counselling

1.4

12.0

827

6511

M10.0

ICD-10 Finland

Idiopathic gout

2.6

11.9

319

M01AB01

ATC

indometacin; systemic, rectal

1.9

11.9

179

975

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.9

11.9

249

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

11.9

116

531

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.1

11.9

126

599

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

11.8

126

600

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

11.8

212

1226

M01AH02

ATC

rofecoxib; oral

1.6

11.8

330

2165

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

11.8

390

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.1

11.8

205

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

11.8

249

1516

F40.1

ICD-10 Finland

Social phobias

2.8

11.7

269

J45

ICD-10 Finland

Asthma

1.7

11.7

255

1568

WZA90

NOMESCO Finland

Other doctors statement

1.4

11.6

608

4559

D05AX02

ATC

calcipotriol; topical

2.2

11.6

114

523

JJC00

NOMESCO Finland

Allogenic transplantation of liver

12.6

11.6

K04.0

ICD-10 Finland

Pulpitis

1.6

11.6

281

1779

A10BX01

ATC

guar gum; systemic

2.5

11.4

371

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

11.4

232

1396

N05AN01

ATC

lithium; oral

2.5

11.4

335

P03

ICPC

Feeling depressed

1.7

11.3

237

1439

C02AC05

ATC

moxonidine; oral

2.2

11.3

113

524

N06AX17

ATC

milnacipran; oral

3.9

11.3

116

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.8

11.3

211

1236

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

5.6

11.3

SPAT1211

SPAT

Application of soft bandage

1.7

11.2

229

1378

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

11.2

150

784

SPAT1252

SPAT

Overall medication plan or its review

1.9

11.2

156

827

L13

ICPC

Hip symptom/complaint

1.5

11.2

367

2500

SPAT1229

SPAT

Assessment of need for aid

1.9

11.2

175

966

C10AB02

ATC

bezafibrate; oral

4.4

11.2

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

11.1

419

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.4

11.1

159

L04AD01

ATC

ciclosporin; systemic

2.8

11.1

254

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

11.1

155

823

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

11.1

241

1477

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.2

11.1

176

A10BG02

ATC

rosiglitazone; oral

3.8

11.0

119

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.3

11.0

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.7

11.0

262

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

8.6

11.0

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

11.0

534

3948

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

11.0

998

8181

N06AX26

ATC

vortioxetine; oral

1.9

11.0

152

805

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

10.9

226

1365

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

10.9

112

526

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

10.9

585

4402

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

10.8

336

F32

ICD-10 Finland

Depressive episode

1.9

10.8

147

773

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

10.8

125

616

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

10.8

323

2155

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.3

10.7

416

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.8

10.7

117

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.6

10.7

296

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

10.7

105

480

L02

ICPC

Back symptom/complaint

1.7

10.7

234

1435

CL2S4

SPAT

6.1

10.7

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.7

10.7

264

M54

ICD-10 Finland

Dorsalgia

1.6

10.7

294

1921

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

10.7

483

3520

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

10.6

296

1937

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.5

10.6

316

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

10.6

860

6924

N05AX08

ATC

risperidone; systemic

1.8

10.6

183

1045

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.2

10.6

102

465

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.4

10.6

362

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

10.6

179

1017

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

1.9

10.5

155

841

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.1

10.5

R55

ICD-10 Finland

Syncope and collapse

1.7

10.5

240

1492

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

10.5

207

1235

SPAT1283

SPAT

Restricted health certificate

1.4

10.5

471

3429

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.6

10.5

305

A08

ICPC

Swelling

2.2

10.4

101

462

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.2

10.4

108

508

R06AX22

ATC

ebastine; oral

1.4

10.4

468

3410

A10BD20

ATC

metformin and empagliflozin; systemic

3.9

10.4

106

L04AC05

ATC

ustekinumab; parenteral

6.8

10.4

S06.0

ICD-10 Finland

Concussion

1.6

10.3

259

1652

C10AA03

ATC

pravastatin; oral

1.9

10.3

155

847

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

10.3

130

664

C09DA06

ATC

candesartan and diuretics; oral

1.8

10.3

188

1096

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

10.3

128

651

N04BC05

ATC

pramipexole; oral

1.8

10.3

177

1012

I50

ICD-10 Finland

Heart failure

3.0

10.3

201

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

10.3

205

1228

E000001

ATC

1.4

10.3

521

3877

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

7.1

10.3

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.3

10.2

387

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

10.2

152

829

B01AC04

ATC

clopidogrel; oral

1.6

10.2

306

2041

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

10.2

211

1279

L60.0

ICD-10 Finland

Ingrowing nail

2.1

10.2

118

583

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

10.2

159

880

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.7

10.1

A04

ICPC

Weakness/tiredness general

1.6

10.1

281

1840

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

7.9

10.1

A10BX02

ATC

repaglinide; oral

4.0

10.1

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

10.1

160

891

S76

ICPC

Skin infection other

2.0

10.0

126

645

J01FA15

ATC

telithromycin; oral

1.6

10.0

279

1830

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

10.0

103

485

N06AX05

ATC

trazodone; oral

2.4

10.0

340

N17

ICPC

Vertigo/dizziness

1.6

10.0

243

1540

A10BJ01

ATC

exenatide; parenteral

3.8

10.0

110

C07AB03

ATC

atenolol; systemic

2.1

10.0

115

570

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

10.0

411

SPAT1097

SPAT

Recording of ECG

1.5

9.9

345

2381

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

9.9

184

1076

P01BA02

ATC

hydroxychloroquine; oral

1.7

9.9

213

1305

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.6

9.9

121

K08.80

ICD-10 Finland

Toothache NOS

1.7

9.8

216

1331

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

3.4

9.8

132

K76

ICD-10 Finland

Other diseases of liver

20.1

9.8

R10.0

ICD-10 Finland

Acute abdomen

2.3

9.8

388

B80

ICPC

Iron deficiency anaemia

3.1

9.8

165

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

9.8

126

651

P29

ICPC

Psychological sympt/compl other

1.8

9.7

152

842

C03BA11

ATC

indapamide; oral

2.5

9.7

312

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.9

9.7

199

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

9.7

128

668

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

9.7

719

5700

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.7

9.7

108

T89

ICPC

Diabetes insulin dependent

2.0

9.7

115

577

A03FA02

ATC

cisapride; oral, rectal

1.8

9.7

180

1054

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.1

9.7

108

528

K76.7

ICD-10 Finland

Hepatorenal syndrome

13.4

9.7

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.5

9.6

288

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

9.6

303

2045

L04AC10

ATC

secukinumab; parenteral

5.5

9.6

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

9.6

112

556

L05

ICPC

Flank/axilla symptom/complaint

1.9

9.6

137

734

F34.1

ICD-10 Finland

Dysthymia

2.1

9.6

107

520

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.2

9.6

448

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.9

9.6

201

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.8

9.6

216

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

9.6

195

1174

K80.8

ICD-10 Finland

Other cholelithiasis

3.1

9.6

162

J01DA06

ATC

[U] cefuroxime; systemic

1.5

9.6

385

2739

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

9.6

312

2122

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

9.5

111

549

C01DA14

ATC

isosorbide mononitrate; oral

1.6

9.5

237

1510

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

9.5

389

M54.2

ICD-10 Finland

Cervicalgia

1.7

9.5

184

1092

ZXA05

NOMESCO Finland

Left side

1.4

9.5

602

4650

N03AG01

ATC

valproic acid; systemic, rectal

1.8

9.5

161

919

SPAT1260

SPAT

Consultation of another employee

1.4

9.5

428

3117

S80.0

ICD-10 Finland

Contusion of knee

1.8

9.5

164

940

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.7

9.4

227

R06AX27

ATC

desloratadine; oral

1.3

9.4

729

5810

SPAT1139

SPAT

Nutrition survey

2.2

9.4

404

A10AB06

ATC

insulin glulisine; parenteral

3.5

9.4

121

A10BB01

ATC

glibenclamide; oral

2.6

9.4

261

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.7

9.4

221

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.8

9.4

164

944

T83

ICPC

Overweight

2.8

9.4

214

C09CA07

ATC

telmisartan; oral

1.7

9.4

181

1072

L29.9

ICD-10 Finland

Pruritus, unspecified

2.7

9.4

237

358

Kela drug reimbursment

liraglutide

5.1

9.4

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

9.3

172

1005

SPAT1216

SPAT

Assessment of functional ability

1.5

9.3

305

2073

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.4

9.3

335

R2110

NOMESCO Finland

Giving the first information

1.7

9.3

179

1062

K70.4

ICD-10 Finland

Alcoholic hepatic failure

6.9

9.3

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

9.3

175

1032

R06AE09

ATC

levocetirizine; oral

1.5

9.3

384

2750

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

4.5

9.2

K04.08

ICD-10 Finland

Other specified pulpit

1.7

9.2

183

1095

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.8

9.2

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.3

9.2

383

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

9.2

1061

8938

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

9.2

209

1299

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

9.2

115

589

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

9.2

396

M01AC06

ATC

meloxicam; systemic, rectal

1.3

9.1

969

8068

XQ800

NOMESCO Finland

Prick test

1.7

9.1

204

1264

UDC00

NOMESCO Finland

Ear microscopy

1.7

9.1

178

1060

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

5.9

9.0

R01AD12

ATC

fluticasone furoate; nasal

1.3

9.0

795

6454

R52.2

ICD-10 Finland

Other chronic pain

2.2

9.0

415

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.5

9.0

295

2011

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.3

8.9

362

R04.0

ICD-10 Finland

Epistaxis

1.8

8.9

154

881

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.0

8.9

115

594

D01AC02

ATC

miconazole; topical

1.7

8.9

192

1179

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

8.9

100

491

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.7

8.9

228

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

8.8

176

1052

C01CA24

ATC

epinephrine; parenteral

1.7

8.8

171

1016

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

8.8

183

1110

J01FA01

ATC

erythromycin; systemic

1.5

8.8

366

2617

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

8.8

119

628

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

8.8

509

3872

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.8

8.8

190

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.0

8.7

108

552

K51.8

ICD-10 Finland

Other ulcerative colitis

3.0

8.7

171

C09AA04

ATC

perindopril; oral

1.9

8.7

120

637

C09DA03

ATC

valsartan and diuretics; oral

1.9

8.7

114

595

J01MA14

ATC

moxifloxacin; systemic

1.6

8.7

219

1401

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

8.7

183

1114

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

8.7

101

504

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.5

8.7

258

R29

ICPC

Respiratory symptom/complaint other

1.8

8.7

157

914

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

8.6

146

831

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.5

8.6

304

2103

S21

ICPC

Skin texture symptom/complaint

1.5

8.6

278

1888

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

8.6

1039

8785

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

8.6

172

1033

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

8.6

437

D82

ICPC

Teeth/gum disease

1.3

8.6

925

7710

E87.5

ICD-10 Finland

Hyperkalaemia

3.4

8.6

115

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

8.5

142

806

D02AE01

ATC

carbamide; topical

1.7

8.5

180

1097

E78.11

ICD-10 Finland

Other hypertriglyceridemia

4.8

8.5

N05BA01

ATC

diazepam; systemic, rectal

1.5

8.5

335

2372

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.7

8.5

205

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

8.5

182

N01

ICPC

Headache

1.6

8.5

240

1579

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.7

8.5

191

1183

SPAT1301

SPAT

No procedures

1.3

8.5

740

5992

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.9

8.5

170

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

8.5

494

3759

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.9

8.4

177

L86

ICPC

Back syndrome with radiating pain

1.8

8.4

137

770

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

8.4

108

560

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

8.4

162

964

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.4

8.4

117

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

8.4

140

793

D07AB08

ATC

desonide; topical

1.5

8.4

265

1789

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.5

8.4

259

1739

T45

ICPC

Metabolic, Observ/health educat/advice/diet

3.0

8.4

156

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.4

8.3

436

3259

W19

ICD-10 Finland

Unspecified fall

1.6

8.3

224

1460

P74

ICPC

Anxiety disorder/anxiety state

2.1

8.3

469

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

8.3

181

1117

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

8.2

1364

11958

K80

ICPC

Cardiac arrhythmia NOS

1.7

8.2

160

952

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

8.2

257

B01AA03

ATC

warfarin; systemic

1.4

8.2

343

2456

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.9

8.2

161

J01EA01

ATC

trimethoprim; systemic

1.3

8.2

567

4434

SPAT1377

SPAT

Polysomnography

2.1

8.2

451

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

4.1

8.1

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

8.1

216

A01AB09

ATC

miconazole; local oral

1.6

8.1

202

1287

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.9

8.1

163

UJK02

NOMESCO Finland

ERCP

2.5

8.1

260

C08CA05

ATC

nifedipine; systemic

1.8

8.1

129

723

R13

ICD-10 Finland

Dysphagia

1.7

8.1

147

860

A05

ICPC

Feeling ill

1.8

8.1

141

812

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

8.1

283

1957

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

8.0

139

798

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

8.0

236

1566

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

8.0

242

1618

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

8.0

365

2659

K76.6

ICD-10 Finland

Portal hypertension

22.1

8.0

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

8.0

126

703

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

8.0

102

528

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.5

8.0

238

SPAT1248

SPAT

OTHER EXAMINATIONS, PROCEDURES, TREATMENT ETC.

5.5

8.0

K04.09

ICD-10 Finland

Pulpit UNS

1.9

8.0

112

601

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

8.0

1040

8858

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

7.9

166

1010

Z00.0

ICD-10 Finland

General medical examination

1.4

7.9

430

3230

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

7.9

2715

25903

Z50.1

ICD-10 Finland

Other physical therapy

1.8

7.9

134

764

I50.0

ICD-10 Finland

Congestive heart failure

1.9

7.9

107

565

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

7.9

633

5060

SPAT1219

SPAT

Assessment of need for vocational rehabilitation

6.6

7.9

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

7.8

987

8367

A02BX02

ATC

sucralfate; oral

2.0

7.8

461

R03AK11

ATC

formoterol and fluticasone; inhalant

2.3

7.8

291

JKA20

NOMESCO Finland

Cholecystectomy

2.4

7.8

253

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.4

7.8

272

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

7.8

144

844

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

7.8

220

1449

A12BA01

ATC

potassium chloride; oral

2.2

7.8

345

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

10.8

7.8

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

7.8

245

1654

Z72.1

ICD-10 Finland

Alcohol use

3.1

7.8

130

SPAT1058

SPAT

PEF monitoring instruction

1.6

7.8

195

1246

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.2

7.8

334

T60

ICPC

Metabolic, Result test/procedure

3.6

7.7

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.5

7.7

229

L40.8

ICD-10 Finland

Other psoriasis

3.9

7.7

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

7.7

234

1569

M54.3

ICD-10 Finland

Sciatica

1.7

7.7

150

894

ECB00

NOMESCO Finland

Suture of gingiva

2.0

7.7

445

G63.2

ICD-10 Finland

Diabetic polyneuropathy

5.6

7.7

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

7.6

168

1037

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

7.6

239

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.6

7.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

7.6

206

1342

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.8

7.6

137

795

J01CF05

ATC

flucloxacillin; systemic

2.0

7.6

502

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

7.6

246

1670

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

4.7

7.6

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

7.6

128

730

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

7.6

503

P99

ICPC

Psychological disorders other

2.2

7.6

355

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

7.6

263

1811

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

7.6

193

1237

H81

ICPC

Excessive ear wax

1.4

7.6

331

2393

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.3

7.6

302

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

7.6

323

L30.4

ICD-10 Finland

Erythema intertrigo

3.4

7.6

100

M54.8

ICD-10 Finland

Other dorsalgia

1.9

7.6

101

533

R03BA01

ATC

beclometasone; inhalant

1.4

7.6

336

2437

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

7.5

307

2188

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

7.5

214

1412

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

7.5

205

1340

JN4BD

NOMESCO Finland

Extensive body CT

1.5

7.5

242

1642

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.8

7.5

168

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.6

7.5

202

L14

ICPC

Leg/thigh symptom/complaint

1.6

7.5

168

1043

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

7.5

640

5160

N48.1

ICD-10 Finland

Balanoposthitis

2.3

7.4

267

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.7

7.4

169

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.8

7.4

163

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.8

7.4

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.4

7.4

240

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

7.4

332

R96

ICPC

Asthma

1.6

7.4

199

1297

C10AB04

ATC

gemfibrozil; oral

4.2

7.4

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

7.4

403

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

7.4

137

808

JN4CD

NOMESCO Finland

Very extensive body CT

2.0

7.4

453

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.4

7.3

262

A07AA02

ATC

nystatin; oral

1.7

7.3

143

852

M54.1

ICD-10 Finland

Radiculopathy

1.9

7.3

103

554

TAB00

NOMESCO Finland

Lumbar puncture

1.8

7.3

116

648

C09DB01

ATC

valsartan and amlodipine; oral

2.1

7.3

395

K60.1

ICD-10 Finland

Chronic anal fissure

2.3

7.3

271

N19

ICD-10 Finland

Unspecified kidney failure

2.3

7.3

271

F33

ICD-10 Finland

Recurrent depressive disorder

2.6

7.3

183

A91

ICPC

Abnormal result investigation NOS

1.9

7.3

102

546

TPH00

NOMESCO Finland

Phlebotomy

5.1

7.2

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

6.2

7.2

JJ5AT

NOMESCO Finland

15.8

7.2

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.4

7.2

C09BA03

ATC

lisinopril and diuretics; oral

2.6

7.2

194

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

7.2

142

851

I84

ICD-10 Finland

Hemorrhoids

2.2

7.2

319

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

7.2

231

1568

A02BC04

ATC

rabeprazole; oral

1.5

7.2

216

1442

D13.4

ICD-10 Finland

Benign neoplasm: Liver

4.6

7.2

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

7.2

332

S22

ICPC

Nail symptom/complaint

1.7

7.2

133

781

F32.8

ICD-10 Finland

Other depressive episodes

2.8

7.2

155

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

7.2

168

1056

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

7.2

430

K70

ICD-10 Finland

Alcoholic liver disease

30.1

7.1

R78

ICPC

Acute bronchitis/bronchiolitis

2.4

7.1

241

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

20.1

7.1

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

7.1

306

2206

N20.9

ICD-10 Finland

Urinary calculus, unspecified

2.2

7.1

313

K80

ICD-10 Finland

Cholelithiasis

3.0

7.1

128

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

4.2

7.1

ZXA10

NOMESCO Finland

Bilateral

1.4

7.1

424

3235

R06.2

ICD-10 Finland

Wheezing

1.9

7.1

101

547

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

7.1

374

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

7.1

287

2044

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.9

7.0

L04AB06

ATC

golimumab; parenteral

3.8

7.0

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.0

7.0

412

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.3

7.0

275

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.7

7.0

152

935

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

7.0

168

1061

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.3

7.0

276

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.6

7.0

182

E86

ICD-10 Finland

Volume depletion

2.6

7.0

182

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

7.0

483

Z72.0

ICD-10 Finland

Tobacco use

2.2

7.0

309

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.1

7.0

343

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

7.0

138

826

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

3.5

7.0

R12

ICD-10 Finland

Heartburn

1.6

7.0

163

1026

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

7.0

305

2208

C02EA02

ATC

2.1

7.0

357

N05AE04

ATC

ziprasidone; systemic

3.8

6.9

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

6.9

311

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

3.0

6.9

119

KH1AD

NOMESCO Finland

CT of urinary organs

2.0

6.9

448

WX882

NOMESCO Finland

High dependency care

2.2

6.9

291

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.8

6.9

118

677

S22.3

ICD-10 Finland

Fracture of rib

1.6

6.9

151

935

H70

ICPC

Otitis externa

2.4

6.9

232

207

Kela drug reimbursment

Chronic arrhythmias

1.5

6.9

243

1684

TNH32

NOMESCO Finland

Custom moulded split, ankle or foot

3.5

6.9

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.7

6.9

163

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

6.8

244

1696

SPAT1153

SPAT

Removal of sutures

1.3

6.8

759

6318

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

3.2

6.8

104

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

5.0

6.8

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.2

6.8

308

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.8

6.8

143

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

6.8

236

1631

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

6.8

209

K76.1

ICD-10 Finland

Chronic passive congestion of liver

40.1

6.8

JAH01

NOMESCO Finland

Laparoscopy

1.8

6.7

117

677

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.2

6.7

276

M75.5

ICD-10 Finland

Bursitis of shoulder

2.2

6.7

276

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

6.7

108

610

A10BD03

ATC

metformin and rosiglitazone; systemic

2.9

6.7

137

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.2

6.7

301

B01AF02

ATC

apixaban; oral

1.6

6.7

170

1093

H92.0

ICD-10 Finland

Otalgia

1.7

6.7

120

699

C05AA08

ATC

fluocortolone; rectal, topical

1.4

6.7

353

2636

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

6.7

129

770

C01AA05

ATC

digoxin; systemic

1.8

6.7

107

600

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.1

6.7

111

N05AF01

ATC

flupentixol; systemic

2.5

6.7

193

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.0

6.7

426

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

6.7

111

634

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

6.7

359

2692

D73.1

ICD-10 Finland

Hypersplenism

22.6

6.7

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.8

6.7

145

EB1AA

SPAT

1.7

6.7

120

703

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

6.7

163

1038

IEY01

NOMESCO Finland

Psychoeducation, individual

3.9

6.7

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.5

6.7

257

1813

X58

ICD-10 Finland

Exposure to other specified factors

1.4

6.6

347

2588

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

6.6

112

639

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

6.6

470

L29

ICPC

Musculoskeletal sympt/complt other

1.6

6.6

166

1064

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

6.6

352

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

6.6

443

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.4

6.6

232

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

6.6

123

727

K85

ICPC

Elevated blood pressure

1.4

6.6

319

2349

Z00.8

ICD-10 Finland

Other general examinations

1.6

6.6

161

1025

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

7.8

6.6

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

6.6

284

2049

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2584

10312

6.16

307.65

5.2

3.3

u/l

44.9

34.6

7.28

2467

9819

(3028026) IgM [Mass/volume] in Serum or Plasma

1400

1805

11.96

307.65

1.5

1.8

g/l

1.2

1.3

1.57

1260

1664

(3017143) Hepatitis C virus Ab [Presence] in Serum

1474

3608

6.18

307.65

1.5

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1493

3605

6.32

307.65

2.4

2.6

25.0

23.8

2.29

1310

3097

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1401

2724

7.73

307.65

2.8

2.2

g/l

0.2

12.76

1311

2557

(3007164) IgA [Mass/volume] in Serum or Plasma

1831

6014

5.10

307.65

1.7

1.5

g/l

2.9

2.4

17.61

1419

3769

(3024561) Albumin [Mass/volume] in Serum or Plasma

2719

12288

5.76

307.65

6.2

4.9

g/l

36.7

36.0

8.98

2603

11489

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3040

15310

6.91

307.65

8.3

6.3

umol/l

12.6

11.2

5.75

2947

14553

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1479

3879

5.73

307.65

2.3

2.5

g/l

2.5

2.3

25.99

1366

3600

(3037522) Nuclear Ab [Titer] in Serum

1640

4256

6.18

307.65

1.5

1.3

titre

533.0

0.00

350

878

(40768441) Liver Pathology biopsy report

336

207

17.78

307.65

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

1337

829

24.88

307.65

1.3

1.2

titre

89.3

83.3

0.18

155

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1313

4231

4.29

307.65

2.1

1.8

1.5

3.79

1097

3782

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

447

248

20.40

307.65

1.2

1.4

titre

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

505

241

24.16

307.65

1.1

1.0

mg/l

285.9

290.2

0.31

436

218

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1194

3454

4.65

307.65

3.4

2.8

umol/l

7.8

7.9

0.01

1061

3026

(3022948) Iron [Moles/volume] in Serum or Plasma

1523

4223

5.47

307.65

2.4

2.5

umol/l

15.1

13.7

9.69

1434

3925

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1503

4370

5.15

307.65

1.5

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

713

397

22.08

307.65

1.1

g/l

1.4

1.5

1.97

632

356

(3034770) Mitochondria Ab [Titer] in Serum

1314

820

24.48

307.65

1.3

titre

625.0

1306.8

1.38

(3005719) IgG [Mass/volume] in Serum or Plasma

1486

2320

10.12

307.65

1.8

2.8

g/l

11.1

10.4

7.11

1354

2128

(3016650) Hepatitis A virus Ab [Presence] in Serum

415

534

8.64

307.17

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1634

6803

3.54

297.72

1.4

1.3

u/ml

1.2

1.8

2.29

345

1860

(3020682) Albumin/Creatinine [Ratio] in Urine

1901

8778

3.43

291.40

4.7

4.0

mg/mmol

8.6

8.7

0.04

1302

5518

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

404

537

8.34

290.72

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3390

23196

7.50

278.52

13.2

7.5

u/l

93.5

76.9

67.71

3302

21957

(3006922) Hepatitis E virus Ab [Presence] in Serum

266

216

13.20

272.79

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1793

8368

3.25

262.96

3.7

3.3

mg/l

257.7

340.2

0.40

1263

5229

(3033658) Prothrombin time (PT) actual/Normal

1685

7647

3.24

258.10

6.0

3.9

93.9

92.9

0.87

1632

7456

(3032080) INR in Blood by Coagulation assay

2129

11111

3.20

254.93

9.0

7.9

inr

1.1

1.2

4.30

673

3265

(3009508) Creatinine [Moles/volume] in Urine

1869

9101

3.16

251.80

3.7

3.2

mmol/l

7.8

0.05

1607

7749

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2300

12655

3.21

249.03

3.6

2.8

ug/l

176.6

125.6

16.27

2147

11835

(44816559) Phosphatidylethanol [Mass/volume] in Blood

387

596

7.15

243.54

1.3

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

240

200

12.77

241.92

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

240

201

12.71

241.17

1.1

1.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1842

9278

2.99

227.08

3.3

2.6

u/l

53.7

58.1

3.22

1701

8608

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3129

21600

4.15

216.12

7.1

3.1

u/l

121.3

47.1

99.60

3009

20366

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

237

240

10.49

209.53

1.3

titre

143.8

220.4

0.63

(42870588) Differential panel, method unspecified - Blood

1897

10089

2.83

205.06

7.5

6.1

—

(3022096) Basophils/100 leukocytes in Blood

2274

13699

2.75

185.91

8.4

6.3

0.7

0.87

2163

12827

(3006504) Eosinophils/100 leukocytes in Blood

2318

14111

2.76

185.37

8.4

6.2

2.9

0.97

2203

13195

(3019069) Monocytes/100 leukocytes in Blood

2327

14197

2.76

185.21

8.7

6.5

8.6

0.39

2219

13354

(3018010) Neutrophils/100 leukocytes in Blood

2335

14425

2.72

178.53

8.2

6.1

56.0

56.6

1.65

2227

13558

(3006315) Basophils [#/volume] in Blood

2412

15162

2.74

177.71

8.3

6.1

e9/l

0.0

4.65

2122

13181

(3002030) Lymphocytes/100 leukocytes in Blood

2353

14613

2.72

177.61

8.6

6.3

29.1

28.7

1.31

2246

13680

(3001604) Monocytes [#/volume] in Blood

2403

15105

2.73

176.56

8.3

6.1

e9/l

0.6

5.88

2115

13143

(3013115) Eosinophils [#/volume] in Blood

2465

15699

2.76

176.29

8.6

6.3

e9/l

0.2

4.09

2196

13872

(3019198) Lymphocytes [#/volume] in Blood

2439

15554

2.71

172.11

8.3

6.1

e9/l

2.1

1.9

1.60

2184

13792

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2051

12222

2.55

163.49

2.9

2.3

nmol/l

71.2

76.8

16.18

1902

11163

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1927

11246

2.51

159.29

2.3

1.9

pmol/l

97.6

96.8

0.28

1061

5840

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

271

448

6.45

158.11

1.3

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2580

17502

2.62

150.32

10.9

9.4

e9/l

4.2

4.0

3.33

2285

15350

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2225

14110

2.48

149.84

8.2

6.8

mmol/l

1.2

0.15

1893

12012

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1333

6709

2.55

149.30

2.9

2.2

mg/l

3.1

2.9

1.17

1200

5746

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

220

310

7.49

148.96

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

400

990

4.41

147.59

1.3

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3034

22433

3.09

147.15

5.7

4.0

mm/h

15.2

11.0

36.81

2880

20950

(3021879) Hepatitis B virus core Ab [Presence] in Serum

666

2407

3.16

139.55

1.4

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2498

17083

2.47

136.34

6.5

4.7

mmol/l

7.5

6.6

40.37

2369

16010

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2029

12811

2.31

131.15

7.0

6.1

mmol/l

1.2

0.40

1895

11685

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

201

298

7.08

129.81

1.2

u/l

58.6

57.4

0.07

135

209

(3026493) Urate [Moles/volume] in Serum or Plasma

1435

7870

2.36

128.83

2.9

2.5

umol/l

5106.5

3968.3

0.41

1254

6957

(3048689) Calprotectin [Mass/mass] in Stool

875

3833

2.69

127.53

3.4

2.4

ug/g

131.1

129.9

0.04

718

3079

(40768797) Stomach Pathology biopsy report

926

4260

2.57

121.42

1.3

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

280

633

4.71

115.17

1.4

2.2

nmol/l

1.1

0.8

6.73

240

538

(3021589) Normoblasts [#/volume] in Blood

2021

13458

2.12

105.37

13.1

9.2

e9/l

0.0

1.39

1665

11032

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3392

28275

3.83

104.76

10.0

5.3

mmol/mol

43.6

39.3

85.04

3273

26489

(36660697) Celiac disease serology panel - Serum

609

2448

2.79

103.11

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

12.85

101.90

1.1

1.3

umol/l

18.3

16.4

1.90

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

676

2888

2.65

101.39

3.0

2.4

u/l

31.6

55.6

0.84

592

2509

(3018418) pH of Serum or Plasma

1418

8355

2.14

100.90

4.3

4.2

7.4

0.46

289

1590

(3018677) aPTT in Platelet poor plasma by Coagulation assay

881

4306

2.38

98.71

2.1

2.2

30.4

29.6

2.91

852

4190

(3023183) Ammonium ion [Moles/volume] in Plasma

260

632

4.35

97.31

5.4

3.1

umol/l

41.9

36.7

1.47

237

556

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

260

649

4.24

93.93

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

14.48

93.91

3.2

3.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

780

3688

2.42

93.64

5.9

6.2

mmol/l

1.1

1.0

0.59

738

3445

(3037467) Urinalysis macro (dipstick) panel - Urine

2659

20120

2.19

93.52

5.4

4.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

228

522

4.59

92.02

1.4

1.7

g/l

0.7

0.8

0.54

190

396

(3018095) Leukocytes [#/volume] in Urine

1580

9974

2.03

90.81

4.2

3.6

e6/l

134.3

86.1

0.59

1114

6972

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

386

1328

3.13

85.87

2.2

1.9

u/l

44.0

39.2

4.15

347

1191

(3021960) Folate [Moles/volume] in Serum or Plasma

1089

6106

2.12

85.36

1.8

1.5

nmol/l

20.4

20.7

0.21

989

5283

(3023368) Bacteria identified in Blood by Culture

1234

7251

2.06

85.25

5.2

4.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

705

3334

2.38

83.69

15.3

20.2

inr

1.2

0.95

111

488

(3036481) Cortisol [Moles/volume] in Serum or Plasma

630

2832

2.48

83.68

2.0

2.2

nmol/l

344.7

369.9

2.63

580

2601

(3009445) Proteinase 3 Ab [Units/volume] in Serum

365

1236

3.17

83.33

1.4

1.6

u/ml

20.2

17.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

274

773

3.75

83.32

1.3

1.4

iu/ml

19.0

20.1

—

(3002582) Erythrocytes [#/volume] in Urine

1372

8460

2.00

82.14

3.6

3.1

e6/l

38.3

109.4

2.65

1057

6443

(3012095) Magnesium [Moles/volume] in Serum or Plasma

895

4761

2.17

79.59

3.5

3.6

mmol/l

0.8

8.88

851

4482

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1394

8722

1.97

79.35

2.6

2.2

u/l

188.5

235.3

1.17

1323

8239

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1211

7223

2.01

79.05

3.0

2.9

ng/l

1070.0

1033.8

0.09

960

6060

(3022145) Colonoscopy Study observation

707

3440

2.31

78.09

1.5

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1273

7766

1.98

77.60

3.4

3.0

e6/l

0.5

0.4

1.22

957

5800

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

123

187

6.77

77.36

1.5

1.6

u/l

6.3

6.8

0.10

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2918

23566

2.19

77.18

4.9

4.0

pmol/l

14.6

14.7

0.49

2703

21688

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3292

28040

2.78

76.42

6.3

4.7

mu/l

1.9

2.1

1.06

3109

25958

(3026782) Osmolality of Urine

962

5361

2.08

75.12

3.0

2.7

mosm/kgh2o

552.3

548.9

0.17

822

4573

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

118

179

6.78

74.36

1.2

1.1

u/l

102.3

81.2

0.69

105

154

(3000570) Elastase.pancreatic [Mass/mass] in Stool

278

854

3.44

74.17

1.4

ug/g

286.8

292.2

0.14

159

482

(36304419) Bacteria [Presence] in Urine

1240

7650

1.94

71.98

3.3

2.9

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

19.24

70.19

1.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

853

4647

2.09

70.14

1.9

1.7

nmol/l

1093.4

1165.2

1.52

654

3575

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3473

30744

3.69

69.50

22.2

12.9

mg/l

18.0

22.5

19.36

3149

23988

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

297

990

3.18

69.31

3.0

3.7

u/ml

47.0

1668.0

0.95

252

845

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

112

174

6.61

68.99

1.2

1.1

u/l

29.0

17.7

0.93

147

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

235

679

3.63

68.78

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2434

18766

1.89

68.66

5.4

4.1

e6/l

343.2

1991.3

2.42

228

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

624

3032

2.28

68.36

3.3

4.5

u/l

228.0

243.3

2.68

593

2878

(3044640) Blood type and Crossmatch panel - Blood

1404

9143

1.87

68.16

2.9

2.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

537

2458

2.39

67.53

7.2

8.3

mmol/l

9.4

9.0

0.58

510

2361

(3002032) Base excess in Venous blood by calculation

532

2428

2.39

67.33

4.2

4.0

mmol/l

1.5

2.0

1.67

433

1977

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

225

649

3.63

65.99

1.3

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

223

643

3.63

65.43

1.2

u/ml

298.3

272.3

0.69

125

404

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

460

1995

2.49

65.00

1.8

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

587

2836

2.27

64.94

2.9

2.7

2.0

1.8

6.30

534

2539

(40758558) Short blood count panel - Blood

1222

7710

1.88

64.78

7.5

7.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3503

31436

3.86

63.10

24.8

14.3

mmol/l

139.4

139.7

13.56

3468

30719

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

291

1012

3.04

63.02

1.6

titre

117.6

410.0

1.65

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

8.68

62.83

1.3

1.5

ug/l

11.0

8.7

3.30

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

222

658

3.53

62.45

1.2

1.4

u/ml

14.2

17.7

—

(3026008) Bacteria identified in Urine by Culture

1224

7805

1.86

62.21

3.8

2.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3383

29835

2.84

61.66

6.7

4.3

mmol/l

6.7

5.9

119.83

3221

27579

(3021447) Carbon dioxide [Partial pressure] in Venous blood

520

2444

2.32

61.16

4.3

4.0

kpa

5.8

5.9

1.11

511

2371

(3023103) Potassium [Moles/volume] in Serum or Plasma

3506

31561

3.83

61.13

25.1

14.4

mmol/l

3.9

4.0

2.91

3470

30785

(3035350) Ketones [Presence] in Urine by Test strip

1950

14393

1.76

59.64

4.2

3.4

estimate

0.0

0.80

424

2585

(3009261) Glucose [Presence] in Urine by Test strip

1966

14576

1.76

58.90

4.3

3.5

estimate

0.0

0.08

399

2566

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1078

6737

1.85

57.55

1.9

1.8

mg/l

1.1

0.03

819

5091

(3007853) Bacteria identified in Skin by Aerobe culture

650

3435

2.09

56.70

1.9

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

965

5847

1.88

56.67

2.0

1.6

pmol/l

31719567.8

38601889.2

0.13

826

4948

(3021601) Nitrite [Presence] in Urine by Test strip

1940

14431

1.74

56.49

5.9

4.6

estimate

0.0

0.50

433

2668

(3048929) Epstein Barr virus Ab [Presence] in Serum

281

1021

2.90

56.13

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

139

6.61

55.73

1.2

1.1

u/l

86.5

76.5

0.67

113

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

783

4448

1.97

55.72

3.2

2.8

e6/l

3.1

2.5

0.75

405

2345

(3014576) Chloride [Moles/volume] in Serum or Plasma

657

3508

2.06

55.64

8.0

7.3

mmol/l

104.1

104.4

0.79

650

3440

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

140

6.57

55.35

1.2

1.1

u/l

24.2

22.0

0.20

110

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

180

507

3.68

54.60

1.1

iu/ml

100.3

1143.4

0.48

117

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

391

1708

2.44

53.96

3.4

3.5

kpa

5.1

5.2

0.50

365

1589

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

197

594

3.45

53.89

1.2

1.4

u/ml

129.6

117.1

0.39

108

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1093

7027

1.79

52.21

2.7

2.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

455

2154

2.27

52.15

2.1

2.8

g/l

68.5

66.7

4.63

409

1984

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

814

4778

1.91

52.11

3.0

2.6

e6/l

1.1

1.0

0.20

434

2664

(3009343) pH of Capillary blood

383

1686

2.42

51.89

3.4

3.5

7.4

0.02

213

(3000850) Epithelial cells [#/volume] in Urine

940

5789

1.84

51.68

2.8

2.5

e6/l

6.9

5.7

1.52

822

5074

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1244

8328

1.75

51.52

1.8

1.7

mmol/l

1.9

1.4

25.15

1062

7073

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3304

29306

2.35

50.63

20.9

11.7

ml/min/173m2

85.9

84.4

3.75

2890

24246

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1840

13765

1.68

50.07

4.5

3.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

367

1621

2.41

49.26

3.4

mmol/l

1.6

1.7

0.20

264

1221

(3042936) Bacteria identified in Isolate by Culture

718

4115

1.93

49.09

2.6

2.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1496

10669

1.68

48.31

4.1

3.3

ng/l

31.1

52.8

1.46

1004

6776

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

739

4318

1.89

47.46

1.8

—

(3023520) Reticulocytes [#/volume] in Blood

433

2085

2.22

47.41

2.6

2.7

e9/l

82.5

71.6

6.10

312

1576

(3013512) EKG study

1207

8161

1.72

47.34

4.2

3.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

301

1236

2.56

47.21

1.1

—

0.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1378

9660

1.69

47.20

3.0

3.4

mmol/l

2.4

1.70

1232

8565

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

431

2078

2.22

47.03

3.5

4.0

ng/l

81.0

84.1

0.32

380

1826

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

540

2846

2.05

46.75

3.1

4.1

ug/l

4.5

20.6

4.04

417

2287

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

874

5414

1.81

46.41

4.3

3.4

ng/l

382.8

458.1

0.19

634

3936

(3000991) Gas panel - Venous blood

457

2296

2.13

44.83

10.3

9.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

867

5422

1.79

44.30

1.7

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

410

1985

2.20

44.15

3.4

3.3

kpa

4.9

4.7

1.56

399

1920

(3004588) Protein electrophoresis panel - Serum or Plasma

379

1785

2.25

43.65

2.1

2.5

—

(3017181) Myelocytes/100 leukocytes in Blood

480

2500

2.06

42.68

4.6

4.3

0.7

0.9

0.70

140

679

(3023487) Leukocytes [#/volume] in Peritoneal fluid

110

6.47

42.64

3.2

2.4

e6/l

292.0

818.9

2.51

(3002179) Metamyelocytes/100 leukocytes in Blood

449

2284

2.10

42.52

4.4

4.1

0.5

0.6

0.55

109

492

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

113

274

4.22

42.22

1.4

1.3

nmol/l

1.8

1.5

1.86

253

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

301

1315

2.40

41.20

4.9

4.4

mmol/l

23.8

24.3

1.23

279

1189

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3557

33174

3.86

41.02

19.8

10.0

u/l

50.5

27.5

285.69

3509

32183

(3025159) Blasts/100 leukocytes in Blood

438

2244

2.08

40.61

4.6

4.4

0.0

0.4

1.00

116

520

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3435

31510

2.54

39.81

6.8

4.7

mmol/l

2.7

2.9

9.50

3277

29437

(3015171) Extractable nuclear Ab [Units/volume] in Serum

283

1227

2.42

39.36

1.4

1.2

u/ml

0.4

1.4

1.43

104

(40760892) CBC W Ordered Manual Differential panel - Blood

1031

6965

1.67

39.04

6.3

4.5

—

(3022313) Gas panel - Capillary blood

283

1232

2.41

39.00

3.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

225

882

2.65

38.67

1.3

1.2

u/ml

72.8

39.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3304

29888

2.12

38.64

5.4

3.8

mmol/l

1.8

1.3

99.51

3119

27804

(3021440) Promyelocytes/100 leukocytes in Blood

450

2380

2.02

38.13

4.7

4.3

0.1

0.2

0.98

130

624

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

214

824

2.70

38.10

1.3

1.2

u/ml

3.8

8.0

1.17

142

(3014111) Lactate [Moles/volume] in Serum or Plasma

457

2435

2.00

37.91

8.9

7.6

mmol/l

1.7

1.3

5.05

443

2351

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

269

1159

2.43

37.91

1.8

g/l

1.5

1.6

0.98

237

1005

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

239

979

2.54

37.53

2.0

1.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

844

5478

1.70

36.84

1.4

1.3

iu/ml

46.4

30.0

0.96

233

1731

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3392

31099

2.29

36.67

6.0

4.3

mmol/l

4.6

4.8

21.09

3262

29224

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

208

814

2.65

35.84

1.3

1.2

u/ml

13.4

6.2

0.31

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3375

30928

2.22

35.74

6.0

4.2

mmol/l

1.3

1.5

198.53

3212

28926

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

180

655

2.84

35.69

4.0

6.1

iu/ml

366.9

418.3

0.13

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.17

34.40

2.8

2.1

e6/l

2723.1

23552.6

0.55

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

801

5210

1.69

34.37

1.4

1.3

u/ml

9.9

11.0

0.14

256

2135

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

303

1435

2.21

34.19

11.5

10.4

mmol/l

24.3

0.06

284

1354

(3033799) Differential panel - Peritoneal fluid

6.28

33.85

2.4

2.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

772

4994

1.69

33.74

2.8

3.0

mmol/l

2.5

2.4

2.62

666

4391

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3526

33049

2.98

33.71

26.1

14.7

umol/l

76.2

75.4

0.68

3526

33040

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

235

1006

2.43

33.54

2.0

2.5

g/l

4.2

3.8

3.40

172

735

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

235

1007

2.43

33.46

2.0

2.5

g/l

7.5

7.3

0.93

180

775

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

235

1007

2.43

33.46

2.0

2.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

173

641

2.78

33.15

1.2

u/ml

10.3

3.5

0.36

(3026692) Albumin [Mass/volume] in Peritoneal fluid

6.75

33.11

1.6

1.4

g/l

11.9

12.1

0.06

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

222

932

2.47

33.05

2.0

2.5

g/l

11.1

10.2

2.11

189

801

(3044889) 12 lead EKG panel

2523

21474

1.57

32.83

4.2

3.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

188

732

2.65

32.71

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

414

2259

1.94

31.79

4.0

3.9

mmol/l

1.2

1.32

377

1980

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

223

955

2.42

31.78

2.1

2.5

g/l

3.0

3.1

1.14

179

755

(3027801) Oxygen [Partial pressure] in Arterial blood

533

3154

1.81

31.73

9.6

7.9

kpa

11.7

12.7

4.08

516

3020

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

510

2982

1.83

31.57

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

513

3007

1.82

31.49

1.7

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

532

3154

1.80

31.45

9.7

8.0

kpa

5.1

0.19

515

3022

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

200

824

2.51

30.98

1.1

u/ml

3.3

5.4

—

114

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

192

776

2.56

30.97

2.2

2.5

g/l

0.0

1.22

171

724

(3003396) Base excess in Arterial blood by calculation

527

3133

1.80

30.83

9.7

8.0

mmol/l

0.7

1.0

1.29

438

2464

(3044007) Cell count panel - Peritoneal fluid

6.01

30.73

2.9

2.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

201

835

2.49

30.59

2.4

2.0

mg/l

11.3

11.1

0.11

190

776

(3002331) Protein [Mass/volume] in Peritoneal fluid

7.22

30.51

1.7

1.4

g/l

25.0

25.2

0.02

(40768804) Tissue Pathology biopsy report

1590

12387

1.50

30.49

2.2

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

304

1511

2.10

30.25

1.7

1.6

—

(3000494) Fungus identified in Specimen by Culture

597

3702

1.73

30.12

1.6

1.5

—

(3033942) Copper [Moles/time] in 24 hour Urine

18.58

29.98

1.2

1.1

umol/24h

1.2

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

2911

25866

1.62

29.11

27.6

15.7

13.9

13.6

15.20

2880

25322

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

236

1085

2.26

28.55

3.9

3.6

mmol/l

24.6

24.8

0.52

226

1015

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

178

723

2.54

28.41

2.2

2.5

g/l

0.0

0.00

157

673

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

154

585

2.70

28.14

2.4

3.5

u/ml

30.5

782.2

1.06

145

543

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

190

800

2.45

28.09

2.2

2.4

g/l

38.3

38.1

0.19

162

699

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

176

717

2.53

27.92

2.3

2.5

g/l

0.0

0.00

157

672

(3016502) Oxygen saturation in Arterial blood

475

2824

1.78

27.60

10.2

8.4

95.6

95.9

0.72

460

2728

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

154

593

2.67

27.40

4.5

3.7

55.8

56.9

0.52

154

593

(3041096) Erythrocytes [Presence] in Urine by Automated

1086

7947

1.52

27.37

4.1

3.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

218

989

2.28

27.21

1.9

1.6

iu/ml

0.3

0.4

0.08

197

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

204

901

2.34

27.10

1.8

1.6

g/l

0.2

0.09

192

855

(1616796) Gas panel - Central venous blood

152

585

2.67

27.07

3.5

3.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

199

873

2.35

26.85

2.2

2.6

g/l

0.5

1.0

1.60

172

777

(3025941) Bacteria identified in Stool by Culture

331

1778

1.95

26.46

1.4

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

163

657

2.55

26.44

1.3

1.2

u/ml

62.2

45.7

0.31

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

243

1170

2.15

26.20

1.6

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

199

895

2.29

25.35

2.6

2.8

g/l

3.6

3.5

0.03

190

851

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

213

991

2.22

25.01

2.1

2.3

83.4

92.4

4.34

194

928

(3027923) C peptide [Moles/volume] in Serum or Plasma

170

4.06

24.48

1.4

1.5

nmol/l

1.8

1.2

2.12

135

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

204

942

2.23

24.40

1.7

1.6

g/l

1.3

1.2

3.99

192

895

(40761511) CBC panel - Blood by Automated count

3437

32319

2.09

24.39

20.4

11.9

—

(3011985) Renin [Units/volume] in Plasma

114

401

2.90

24.09

1.4

1.5

mu/l

84.6

46.5

1.21

105

361

(3015235) Bicarbonate [Moles/volume] in Capillary blood

159

663

2.46

24.01

2.5

3.2

mmol/l

24.2

24.8

0.86

138

583

(3028626) Oxygen [Partial pressure] in Capillary blood

146

587

2.55

23.82

2.4

2.8

kpa

8.4

8.2

0.72

136

543

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

530

3377

1.67

23.75

1.8

1.6

—

(40761536) Microorganisms panel - Urine sediment

409

2429

1.77

23.68

4.0

3.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

299

1611

1.93

23.63

3.4

3.3

g/l

131.6

130.5

0.31

294

1569

(4035726)

432

2628

1.73

22.95

1.3

1.4

—

(3021901) Oxygen saturation in Capillary blood

123

467

2.69

22.53

2.4

2.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

106

372

2.90

22.52

1.1

—

(3036489) Thrombin time

230

1150

2.07

22.44

1.9

2.2

22.9

21.5

1.21

201

998

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

192

896

2.21

22.38

2.2

2.6

189.1

184.2

0.29

183

852

(3052851) Hemolysis interference index of Serum or Plasma

187

868

2.22

22.09

3.0

3.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

917

6720

1.49

22.08

3.8

3.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

502

2.61

21.99

1.7

2.9

u/ml

551.4

1697.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

107

384

2.84

21.83

1.3

u/ml

63.0

40.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

199

952

2.15

21.80

2.4

ug/l

728.2

812.8

0.10

176

893

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

179

822

2.24

21.70

3.4

3.6

mg/l

1.6

1.4

1.44

162

771

(3020191) Ethanol [Moles/volume] in Serum or Plasma

264

3.23

21.58

1.8

1.5

promille

0.8

1.3

2.23

210

(3034274) Bile acid [Moles/volume] in Serum --fasting

270

3.20

21.46

2.1

umol/l

15.3

6.8

1.92

186

(3012501) Base excess in Blood by calculation

144

605

2.44

21.42

4.2

mmol/l

2.5

0.08

412

(3002173) Hemoglobin [Mass/volume] in Arterial blood

429

2656

1.70

21.31

10.9

8.8

g/l

122.2

123.4

0.56

419

2560

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

178

824

2.22

21.17

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

105

381

2.81

20.99

1.4

pmol/l

296.0

289.4

0.09

301

(3014765) Yersinia sp identified in Stool by Organism specific culture

191

913

2.15

20.97

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

155

681

2.33

20.86

2.2

2.4

ug/min

144.2

117.3

0.25

429

(3027135) IgG subclass 1 [Mass/volume] in Serum

333

2.93

20.84

1.3

1.4

g/l

6.9

6.7

0.15

229

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

458

2908

1.66

20.64

3.7

3.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

171

787

2.23

20.63

2.9

3.8

mg/l

43.9

62.4

1.09

137

630

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

171

788

2.23

20.56

2.9

3.8

mg/l

35.4

53.2

0.93

136

632

(42529406) Shigella sp [Presence] in Stool by Culture

191

920

2.14

20.56

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

332

2.91

20.36

1.3

1.4

g/l

0.4

0.24

227

(3000492) Spirometry study

496

3224

1.62

20.34

1.5

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

333

2.90

20.25

1.3

1.4

g/l

3.1

3.0

0.46

229

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

208

1041

2.06

20.24

1.9

2.1

ug/l

2.1

2.0

0.04

193

939

(40768443) Skin Pathology biopsy report

239

1261

1.96

20.06

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

219

3.33

19.52

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

219

3.33

19.52

1.2

—

(4062490)

335

2.85

19.46

1.3

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

186

907

2.11

19.40

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

220

3.32

19.38

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

165

768

2.20

19.37

2.9

3.7

ratio

1.2

2.3

0.68

(3019225) pH of Specimen

437

2789

1.64

19.23

4.9

4.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

222

3.29

19.11

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

222

3.29

19.11

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

222

3.29

19.11

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

174

834

2.14

18.98

2.6

3.6

u/ml

0.3

0.42

106

468

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

344

2071

1.73

18.85

2.5

2.8

ng/l

161.0

156.1

0.08

309

1869

(3003327) Ova and parasites identified in Stool by Light microscopy

202

1040

2.00

18.19

1.8

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1379

11190

1.37

17.98

4.6

3.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

136

603

2.30

17.96

5.2

4.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

177

873

2.08

17.93

1.5

1.4

u/l

9.8

9.7

0.03

143

706

(3010421) pH of Blood

155

728

2.18

17.81

4.2

7.4

0.16

141

595

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

323

1960

1.71

17.16

2.7

3.4

pmol/l

4.5

0.11

286

1759

(3013139) Helicobacter pylori Ag [Presence] in Stool

335

2061

1.69

16.91

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

263

1517

1.79

16.69

12.8

10.9

—

(3002256) Pathology report gross observation

553

3846

1.52

16.65

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

143

3.67

16.47

1.1

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

196

1042

1.93

16.09

1.8

1.6

mu/l

268.2

307.9

1.61

177

945

(3004616) Nuclear Ab [Presence] in Serum

383

2.55

16.01

1.3

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

126

570

2.25

15.90

2.6

15.7

16.6

1.14

292

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

220

1221

1.85

15.83

2.9

0.6

0.7

0.45

213

1169

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

201

1086

1.90

15.73

6.1

5.9

1.6

1.7

0.36

192

1012

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

224

1255

1.84

15.64

3.0

2.9

1.4

1.3

1.20

224

1246

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

127

584

2.22

15.41

1.8

1.5

—

(4146454)

303

2.71

15.37

2.9

2.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

326

2.65

15.37

1.5

1.4

iu/ml

22.6

25.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

266

1578

1.74

15.32

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

329

2067

1.65

15.30

1.4

1.3

u/ml

234.5

205.0

0.37

314

1912

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

341

2167

1.63

15.15

1.2

iu/ml

115.5

151.3

0.84

120

830

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

107

462

2.36

15.06

1.4

1.2

u/l

17.8

40.0

2.15

396

(1002224) Polysomnography panel

263

1567

1.73

14.91

1.1

—

(3037121) Protein [Mass/volume] in Urine

181

965

1.92

14.75

3.0

3.3

g/l

0.3

0.38

419

(40760888) Immunoglobulin light chains.free panel - Serum

127

595

2.18

14.73

2.5

4.0

—

(3019060) Gas panel - Arterial blood

289

1782

1.68

14.44

5.7

5.3

—

(3000330) Specific gravity of Urine by Test strip

228

1318

1.78

14.36

4.5

3.2

—

(3037756) Immunofixation for Serum or Plasma

117

536

2.22

14.35

1.4

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

242

2.84

14.20

1.1

1.2

u/ml

48.7

49.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

123

579

2.16

14.11

1.3

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

194

1077

1.85

13.97

6.1

6.0

0.9

0.73

185

1004

(3007461) Platelets [#/volume] in Blood

3567

34624

2.34

13.67

33.9

18.9

e9/l

249.1

253.9

3.72

3521

33854

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

121

576

2.14

13.51

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

121

576

2.14

13.51

1.5

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

503

3572

1.47

13.50

5.7

4.3

28.1

31.7

11.31

422

2487

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

759

5807

1.39

13.48

1.6

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

250

2.75

13.39

1.1

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

961

7645

1.35

13.31

4.8

3.8

estimate

0.0

0.21

416

2590

(3035941) MCH [Entitic mass]

3567

34645

2.32

13.29

33.7

18.8

30.3

0.26

3547

34238

(3024731) MCV [Entitic volume]

3567

34647

2.31

13.25

33.7

18.8

90.8

0.18

3547

34241

(3006184) Hemoglobin [Mass/volume] in Capillary blood

124

602

2.10

13.17

2.0

2.2

g/l

129.6

131.4

0.28

427

(3026361) Erythrocytes [#/volume] in Blood

3567

34652

2.31

13.16

33.9

18.9

e12/l

4.6

3.99

3517

33798

(3004809) Band form neutrophils/100 leukocytes in Blood

433

2.30

13.13

2.9

3.3

0.9

1.4

1.32

345

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

146

3.32

13.12

1.6

1.7

nmol/l

1.9

7.8

1.09

121

(3010813) Leukocytes [#/volume] in Blood

3567

34658

2.30

13.05

33.9

18.9

e9/l

7.1

6.6

22.07

3518

33799

(3000963) Hemoglobin [Mass/volume] in Blood

3567

34663

2.29

12.96

34.1

19.0

g/l

137.9

137.3

1.19

3548

34248

(3004716) Salmonella sp identified in Stool by Organism specific culture

266

1653

1.66

12.89

1.3

1.4

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

8.45

12.37

1.4

1.7

63.6

64.7

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

314

2.48

12.35

2.0

2.3

33.0

32.6

0.26

314

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

216

2.81

12.31

1.1

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

228

2.75

12.23

1.3

mmol/l

12.5

12.0

0.25

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

143

3.25

12.16

2.4

2.0

ug/min

97.3

188.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

3068

28867

1.39

11.82

24.5

13.7

40.4

40.5

0.17

2275

21948

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

137

3.24

11.62

3.4

mg/l

7.4

7.8

0.15

115

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

125

640

1.99

11.52

1.3

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

415

2.22

11.36

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

124

3.33

11.34

3.1

2.9

au/ml

133.3

127.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

129

3.28

11.34

5.0

2.7

—

(3021788) Differential panel - Synovial fluid

107

521

2.09

11.32

1.7

1.6

—

(3024928) Oxygen saturation in Venous blood

119

605

2.00

11.20

3.0

3.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

444

2.17

11.17

1.3

nmol/l

0.2

0.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

255

1629

1.61

11.08

1.1

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

277

2.48

10.97

3.2

2.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

371

2.27

10.89

1.3

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2304

20928

1.27

10.78

3.2

3.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

444

2.15

10.78

1.3

nmol/l

0.6

0.10

427

(3028707) Methadone [Presence] in Urine by Screen method

110

553

2.02

10.70

2.4

3.1

—

(3041354) Potassium [Moles/volume] in Venous blood

284

2.42

10.42

3.2

2.4

mmol/l

4.0

0.29

278

(3035285) Chloride [Moles/volume] in Venous blood

284

2.42

10.42

3.2

2.4

mmol/l

105.0

105.7

0.68

278

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

325

2226

1.50

10.36

2.3

2.4

au/ml

20.6

23.1

—

142

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

231

1465

1.62

10.35

2.6

2.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

106

535

2.01

10.21

2.9

3.1

—

(21494755) Public health laboratory ask at order entry panel

245

3686

0.64

10.19

1.4

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

164

960

1.74

9.96

1.3

miu/ml

255.0

215.5

0.55

464

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

151

863

1.78

9.96

2.5

2.8

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

8.15

9.73

1.2

1.8

—

(4010399)

307

2113

1.49

9.55

1.5

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

171

2.77

9.54

1.5

1.3

nmol/l

134.8

134.0

0.04

171

(3017446) Testosterone [Moles/volume] in Serum or Plasma

351

2488

1.45

9.41

2.9

2.2

nmol/l

11.9

13.5

3.26

316

2240

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

179

1097

1.66

9.21

2.1

2.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

4.59

9.05

3.4

2.0

mmol/l

8.8

7.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

176

2.69

9.05

1.3

1.4

u/ml

24.3

22.9

—

(4306422)

511

1.96

9.00

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

369

2.14

8.97

1.3

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

160

2.77

8.96

2.4

2.6

u/ml

689.1

1085.5

1.30

160

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

165

999

1.68

8.90

1.9

1.8

—

(3022621) pH of Urine by Test strip

268

1822

1.51

8.86

4.0

2.7

—

(3000034) Microalbumin [Mass/volume] in Urine

281

2.30

8.82

3.0

mg/l

60.8

57.5

0.03

208

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

473

1.99

8.82

1.2

1.3

—

(3003181) Sodium [Moles/volume] in Urine

455

2.00

8.69

1.5

1.3

mmol/l

59.5

64.1

0.41

364

(3025468) Yersinia sp identified in Specimen by Organism specific culture

354

2.14

8.69

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

354

2.14

8.69

1.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

356

2.13

8.57

1.3

1.5

—

(3024471) HLA-A [Type]

126

2.96

8.49

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

6.86

8.44

1.2

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

3.48

8.36

1.1

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

117

3.01

8.30

2.7

1.9

mg/l

9.1

9.3

0.06

(3004775) Volume in Urine collected for unspecified duration

233

2.38

8.24

2.0

2.3

716.0

618.6

0.70

162

(3024932) HLA-DR beta [Type]

123

2.95

8.22

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

259

2.30

8.17

2.5

3.5

54.7

57.1

0.30

172

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

487

1.93

8.14

1.1

123.0

116.6

0.95

445

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

392

2.04

8.06

1.2

1.3

nmol/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

365

2.08

8.06

1.3

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

503

1.91

8.06

1.3

1.2

u/ml

3.8

4.7

0.33

213

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

368

2.06

7.89

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

362

2.07

7.85

1.3

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

132

2.82

7.84

2.2

2.8

umol/l

226.4

158.0

0.21

(3044290) Cell count panel - Cerebral spinal fluid

112

637

1.78

7.59

1.4

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

119

692

1.74

7.48

1.7

e6/l

9096.8

12174.7

0.71

509

(3042733) HLA Ab [Presence] in Serum

125

2.82

7.42

1.7

5.1

—

(3000012) Reticulocyte production index

131

2.77

7.37

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

214

2.36

7.36

1.3

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

548

1.83

7.35

2.2

1.7

—

(3005570) Glucose [Moles/volume] in Urine

272

2.19

7.31

1.8

2.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.40

7.24

1.1

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

127

2.77

7.21

2.1

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

127

2.77

7.21

2.1

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

516

1.84

7.18

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

230

2.28

7.12

1.2

—

(3049717) Cytology report of Urine Cyto stain

153

966

1.61

7.07

2.3

2.5

—

(44806420)

3.50

6.98

2.5

—

(3036603) Volume of Urine

195

2.38

6.94

1.8

1.4

2056.8

2062.3

0.00

(3042631) Mycobacterium sp identified in Specimen

359

2.00

6.93

3.3

2.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

109

2.86

6.78

1.4

7.8

mg/l

71.5

70.0

0.04

(4281824)

323

2.03

6.67

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

217

1502

1.47

6.62

1.4

1.3

iu/l

27.1

31.4

1.25

180

1288

(4198724)

151

2.53

6.59

1.7

3.2

—

(3044941) Cell count panel - Synovial fluid

466

1.84

6.55

1.6

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.30

6.41

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

154

998

1.57

6.40

2.0

2.3

—

(3044927) Protein electrophoresis panel - Urine

256

2.13

6.29

1.5

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

188

1278

1.50

6.28

1.9

2.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

5.47

6.28

1.8

2.3

mg/l

3.1

3.2

0.07

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

167

2.41

6.27

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

133

837

1.61

6.27

2.4

3.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

242

1732

1.43

6.20

8.5

7.4

mmol/l

24.0

24.6

1.60

227

1616

(3017732) Neutrophils [#/volume] in Blood

292

2162

1.38

6.15

3.1

2.9

e9/l

4.2

4.1

0.50

239

1748

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

145

2.50

6.10

1.4

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.76

6.08

1.8

—

(3027944) Amphetamines [Presence] in Urine

185

1263

1.49

6.07

1.9

2.2

—

(3051611) Lipemic interference index of Serum or Plasma

281

2.04

6.01

3.4

3.1

—

(3003694) ABO and Rh group [Type] in Blood

965

8340

1.21

5.97

1.4

—

(3027008) Opiates [Presence] in Urine

187

1285

1.48

5.94

1.9

2.1

—

(3022689) Creatine [Moles/volume] in Urine

2.86

5.93

1.3

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

136

873

1.58

5.92

2.8

2.2

u/l

3159.8

4298.3

0.31

336

(3040151) Glucose [Moles/volume] in Capillary blood

290

2.02

5.89

12.1

5.0

mmol/l

11.2

7.2

0.97

242

(3011648) Oxygen content in Venous blood

243

2.11

5.89

2.0

2.8

12.0

10.9

0.78

243

(21494890) Protein electrophoresis panel - 24 hour Urine

270

2.05

5.87

1.7

2.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

346

1.92

5.87

2.9

3.0

nmol/l

5.3

21.5

0.51

339

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

185

2.29

5.87

1.5

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

100

596

1.70

5.84

1.8

1.7

—

(3028300) Cannabinoids [Presence] in Urine

187

1291

1.47

5.81

1.9

2.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

124

783

1.60

5.79

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

102

2.76

5.78

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

515

1.75

5.78

1.3

1.2

u/ml

5.1

3.4

0.24

168

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

143

2.46

5.77

1.5

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

303

2282

1.36

5.74

2.2

2.3

ug/l

6.9

8.0

0.44

269

2037

(3047181) Lactate [Moles/volume] in Blood

134

868

1.56

5.63

7.5

7.0

mmol/l

1.7

1.3

2.96

120

758

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

455

1.78

5.53

1.1

u/ml

3.6

3.0

0.18

226

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

197

2.20

5.50

1.2

1.1

ratio

1.1

1.0

0.27

(3018405) Lactate [Moles/volume] in Arterial blood

148

988

1.52

5.44

4.5

4.0

mmol/l

1.6

1.4

1.73

143

973

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

124

798

1.57

5.37

1.3

1.4

mg/l

680.1

519.2

0.80

118

755

(21494434) Karyotype in Bone marrow

239

2.06

5.36

1.1

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

508

1.71

5.23

1.5

1.8

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

356

1.84

5.11

1.6

58.1

57.9

0.01

221

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

378

1.81

5.10

6.5

6.6

mg/l

11.2

11.5

0.22

354

(3017315) Amylase [Enzymatic activity/volume] in Urine

146

2.34

5.07

1.1

1.3

u/l

401.4

351.9

0.08

136

(3016879) Cocaine [Presence] in Urine

171

1194

1.45

5.06

2.0

2.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.91

5.03

1.2

pmol/l

283.0

260.6

0.14

(3004347) Hepatitis D virus Ab [Presence] in Serum

10.02

5.02

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.28

5.02

1.1

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

111

708

1.59

5.02

1.2

1.3

mmol/l

4.0

3.8

1.19

102

667

(3026250) Tacrolimus [Mass/volume] in Blood

160

2.26

4.97

28.5

32.4

ug/l

7.1

7.6

0.89

143

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

199

2.12

4.97

1.1

iu/ml

6.8

10.1

0.69

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

281

1.94

4.96

1.5

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

154

2.29

4.95

27.1

26.5

ug/l

129.3

115.8

0.66

125

(3032773) Endomysium IgG Ab [Titer] in Serum

248

1.99

4.88

1.1

1.0

titre

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

134

900

1.51

4.82

1.4

1.3

—

(3020491) Glucose [Moles/volume] in Blood

222

2.04

4.81

1.8

mmol/l

7.4

6.9

0.39

140

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.59

4.78

2.5

3.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

294

1.88

4.69

2.4

4.1

—

(3028433) Virus identified in Specimen by Culture

2.59

4.63

1.3

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

159

2.21

4.62

2.1

3.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.22

4.61

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

128

861

1.50

4.59

1.2

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.69

4.58

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

118

785

1.52

4.47

1.9

2.0

pmol/l

196.8

207.5

0.43

106

745

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

258

3335

0.76

4.47

1.9

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

117

2.40

4.47

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

117

2.40

4.47

1.3

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

257

1.92

4.44

3.0

2.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

373

1.76

4.43

1.1

102.7

97.1

0.89

351

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

149

2.23

4.43

1.1

1.0

106.3

94.1

1.16

118

(3009466) Valproate [Moles/volume] in Serum or Plasma

480

1.66

4.39

6.5

5.7

umol/l

359.6

371.8

0.30

422

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

504

1.64

4.36

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

204

2.02

4.31

2.4

2.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

107

703

1.54

4.31

1.4

1.5

e6/l

4537.5

1323.8

0.35

576

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

118

793

1.50

4.28

1.8

1.9

iu/l

3.7

4.9

0.84

295

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

275

1.87

4.26

1.6

—

(3016750) Collection duration of Urine

185

2.07

4.24

1.9

2.2

min

495.7

489.3

0.17

140

(3051101) Glucose [Moles/volume] in Cord blood

3.62

4.20

5.7

6.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

106

702

1.53

4.13

1.3

1.5

e6/l

42.9

26.4

0.42

547

(3017704) Immunofixation for Urine

154

2.15

4.11

1.6

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

135

2.23

4.08

1.0

1.1

u/ml

4.8

6.9

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

135

2.23

4.08

1.6

1.7

umol/l

2.3

2.0

0.84

124

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

983

8759

1.17

4.06

4.3

4.2

ug/l

1.9

2.1

0.57

887

7937

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

339

1.75

4.04

1.6

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

172

1258

1.39

3.99

1.8

1.7

mg/l

4.1

0.01

153

888

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

176

2.06

3.99

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

121

830

1.47

3.99

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.82

3.95

1.2

2.2

—

(3045424) Erythrocytes [Presence] in Urine

526

1.59

3.94

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

335

1.74

3.91

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

145

2.15

3.86

1.6

1.4

4.1

4.6

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

7.29

3.86

1.1

1.0

—

(3020891) Body temperature

154

1115

1.40

3.81

5.0

4.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

173

2.03

3.79

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.84

3.79

1.1

umol/24h

0.8

0.7

—

(3051651) Icteric interference index of Serum or Plasma

180

2.01

3.78

3.3

—

(3008898) HLA-B27 [Presence]

162

1185

1.38

3.78

1.1

—

(3019150) Specific gravity of Urine by Refractometry

720

6291

1.18

3.76

4.8

3.8

kg/l

1.0

0.23

128

883

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

140

2.15

3.76

1.4

1.3

u/l

9.6

10.7

0.50

127

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

317

1.75

3.75

1.4

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

463

1.61

3.72

1.7

1.3

—

(3014271) Vancomycin [Susceptibility]

115

2.27

3.70

4.4

2.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

141

2.14

3.70

1.9

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

404

1.65

3.62

2.7

3.1

nmol/l

0.8

0.07

314

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.26

3.62

1.0

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

397

1.65

3.60

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

571

1.54

3.58

1.1

u/ml

3.8

4.7

0.24

282

(3025018) Bordetella pertussis Ab [Titer] in Serum

184

1.97

3.57

1.4

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

540

1.55

3.55

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

234

1.85

3.55

1.4

1.2

u/ml

0.4

0.7

0.38

103

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

213

1.89

3.53

1.4

1.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

6.16

3.50

1.0

1.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

6.16

3.50

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

324

1.71

3.50

1.3

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.18

3.49

1.1

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.37

3.48

1.0

1.2

113.9

108.1

0.26

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.34

3.47

1.0

1.1

u/ml

0.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

456

1.59

3.47

1.3

1.4

u/l

26.1

28.4

0.20

368

(3045414) Leukocytes [Presence] in Urine

179

1352

1.34

3.44

2.1

1.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

204

1572

1.32

3.41

2.6

3.4

u/ml

79.2

54.3

0.46

193

1520

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.66

3.39

1.1

1.3

—

(3048879) Bone marrow aspiration report

2.58

3.38

1.8

2.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

140

2.08

3.37

2.1

2.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

363

3007

1.23

3.36

2.0

1.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.32

3.33

1.0

1.1

100.8

91.0

1.07

(3001556) Androgen free Index in Serum or Plasma

3.44

3.33

1.5

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

352

1.66

3.32

1.7

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.72

3.32

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.72

3.32

1.7

2.2

umol/l

12.1

17.3

1.23

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

323

1.68

3.27

2.6

2.2

mg/l

18.4

22.8

0.20

(3019977) pH of Arterial blood

142

2.05

3.26

2.2

2.9

7.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

354

1.65

3.26

1.1

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

102

708

1.45

3.24

1.5

1.7

—

(3023410) Appearance of Cerebral spinal fluid

310

1.69

3.19

1.6

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

450

1.57

3.19

1.3

1.5

nmol/l

0.2

0.3

0.74

335

(3042111) Morphology [Interpretation] in Bone marrow Narrative

466

1.56

3.19

1.3

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

164

1.96

3.18

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

100

694

1.45

3.18

1.5

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

214

1.83

3.17

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

172

2236

0.76

3.16

1.5

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

397

3344

1.21

3.12

2.1

2.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

275

1.72

3.10

1.7

2.3

45.1

44.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

367

1.62

3.09

2.2

2.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

526

1.51

3.09

1.1

u/ml

0.5

2.3

2.61

127

(44806071)

3.08

3.09

1.3

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

112

2.15

3.06

1.1

1.2

g/l

0.3

1.12

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

217

1.81

3.05

1.2

—

(3008295) Osmolality of Serum or Plasma

315

1.66

3.03

1.3

1.4

mosm/kgh2o

276.8

280.0

0.38

242

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

113

2.13

3.00

1.5

2.0

162.5

169.2

0.09

106

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

278

1.70

2.99

1.6

1.5

28.6

34.3

0.47

171

(3043410) Blood group antigens tested for on Red Blood Cells

2.35

2.98

1.7

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

938

0.64

2.96

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

114

2.11

2.94

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

121

2.07

2.92

1.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

397

1.57

2.91

1.5

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

299

2472

1.23

2.85

2.7

2.5

ml/min/173m2

68.4

69.7

0.19

125

916

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

393

1.56

2.80

1.4

1.6

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

137

1.98

2.79

1.6

umol/l

31.7

29.4

0.28

132

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.47

2.78

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

209

1.78

2.78

1.5

2.1

u/field

3.2

1.9

0.52

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.92

2.77

1.0

1.1

—

(4268621)

348

1.59

2.73

2.4

2.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

2.43

2.70

3.3

2.8

u/l

64.3

105.5

—

(3002619) Bacteria identified in Specimen by Culture

2.60

2.70

1.6

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.18

2.67

1.0

1.3

99.0

91.2

0.51

(3043409) Potassium [Moles/volume] in Arterial blood

115

848

1.37

2.65

4.9

4.2

mmol/l

3.8

3.9

1.56

107

808

(37021550) Renin [Units/volume] in Plasma --upright

2.33

2.65

1.2

1.4

mu/l

123.7

55.0

0.88

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.80

2.64

1.3

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

432

1.51

2.62

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.67

2.59

1.3

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

170

1.83

2.58

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.73

2.54

1.4

1.5

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

5.46

2.54

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

411

1.52

2.54

1.4

1.3

mmol/l

8.1

7.4

0.90

307

(3050129) First trimester maternal screen panel - Serum or Plasma

601

0.60

2.53

1.5

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

643

1.41

2.52

1.1

u/ml

1.2

1.6

0.34

253

(3023419) Bacteria identified in Sputum by Culture

356

1.55

2.51

3.5

2.8

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

129

1.94

2.50

1.2

1.1

iu/ml

262.5

195.3

0.48

129

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

270

1.64

2.49

3.1

4.1

—

(3039000) Anion gap in Blood

628

1.41

2.48

9.7

8.2

mmol/l

12.1

11.3

1.16

561

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

326

0.46

2.47

1.5

—

(3018572) Chloride [Moles/volume] in Blood

629

1.41

2.46

9.7

8.2

mmol/l

104.5

105.3

0.80

562

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

116

1.99

2.45

1.0

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.55

2.44

1.3

2.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.34

2.39

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

483

1.46

2.38

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

6.26

2.37

1.0

1.5

nmol/l

2.4

2.0

—

(3017569) Oxygen content in Arterial blood

139

1.88

2.36

2.3

2.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

331

1.55

2.32

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.19

2.30

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

284

1.59

2.30

1.7

1.5

g/l

30.2

33.4

0.80

253

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.07

2.27

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

120

1.92

2.25

3.9

3.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.10

2.22

1.1

u/ml

0.5

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

114

1.94

2.20

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

233

1.64

2.19

1.4

2.1

9.7

13.1

1.52

101

(3032057) Clostridioides difficile [Presence] in Stool

2.41

2.19

1.7

2.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

551

1.41

2.18

1.1

u/ml

1.0

1.3

0.29

223

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

226

1.64

2.17

1.4

1.8

—

(4211845)

136

1.84

2.17

3.6

3.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

375

3254

1.17

2.16

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.69

2.15

1.3

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.69

2.15

1.3

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.00

2.14

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.30

2.14

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

137

1.83

2.13

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

197

1.68

2.12

1.0

1.1

nmol/l

0.1

5.8

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

291

1.55

2.11

1.8

ug/l

49.5

25.6

0.37

286

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.01

2.07

1.0

1.2

mmol/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.01

2.07

37.8

4.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

117

1.89

2.06

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.98

2.05

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

103

1.95

2.05

2.4

2.7

umol/l

27.2

29.5

—

(3011412) CD3 cells [#/volume] in Blood

302

1.53

2.03

1.9

2.5

e9/l

1.5

1.2

1.34

176

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

118

1.87

2.01

2.5

2.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

696

0.67

2.01

1.4

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.64

2.01

10.0

8.2

mmol/l

5.0

6.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.23

2.00

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.82

2.00

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

194

1.66

1.96

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

202

1.64

1.95

2.1

2.7

e9/l

0.2

0.37

174

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.94

1.95

1.1

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

265

1.55

1.94

1.8

1.4

e6/l

1269.0

2601.6

1.32

191

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

210

1.62

1.94

2.1

2.7

e6/l

559.0

556.3

0.01

175

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.73

1.93

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

211

1.62

1.91

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1101

0.75

1.88

1.4

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.31

1.87

1.8

1.7

ng/l

84.0

111.9

0.75

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

261

1.54

1.84

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

261

1.54

1.84

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

261

1.54

1.84

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

452

1.40

1.81

1.0

1.1

u/ml

0.9

2.9

2.05

168

(4015189)

2.06

1.80

1.9

2.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.58

1.80

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.05

1.80

1.4

umol/24h

464.4

332.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.96

1.79

1.2

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

420

1.41

1.77

1.3

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

412

1.41

1.77

1.0

1.1

u/ml

1.5

4.6

2.17

161

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

224

1.57

1.76

1.4

2.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.94

1.74

1.1

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.94

1.74

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

1.98

1.74

1.4

2.2

e6/l

216.7

150.0

—

(3003338) MCHC [Mass/volume]

2762

26959

1.10

1.74

28.7

16.3

g/l

332.8

333.0

0.53

2748

26789

(3043238) Trisomy 21 risk [Likelihood] in Fetus

422

0.61

1.73

1.4

1.5

—

(3042517) Benzodiazepines panel - Urine

2.67

1.72

6.0

2.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

409

0.61

1.72

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

395

0.60

1.69

1.9

1.7

—

(3047189) Immunofixation for 24 hour Urine

133

1.73

1.69

1.6

1.8

—

(3005033) Fetal Nuchal fold Thickness US

407

0.61

1.69

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

187

1.61

1.68

1.0

u/ml

1.0

0.8

0.08

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

537

0.67

1.65

1.4

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.03

1.64

1.3

1.1

—

(3012441) Differential panel - Pleural fluid

229

1.53

1.62

1.6

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

498

0.66

1.61

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

498

0.66

1.61

1.3

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

532

1.34

1.60

1.3

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.95

1.59

2.2

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.95

1.59

2.2

2.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

136

1.70

1.58

1.1

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

496

0.66

1.58

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

496

0.66

1.58

1.3

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

121

1.74

1.58

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

129

1.71

1.56

1.1

1.7

—

(1761868) Lipid panel - Serum or Plasma

1281

12151

1.08

1.54

3.7

2.7

—

(3023383) Lactate [Moles/volume] in Pleural fluid

2.03

1.54

1.8

1.4

mmol/l

3.2

3.3

0.06

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.86

1.50

3.0

4.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.16

1.50

1.0

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

154

1.63

1.49

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

154

1.63

1.49

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

154

1.63

1.49

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

154

1.63

1.49

2.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.44

1.47

1.2

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

334

1.41

1.47

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

109

1.75

1.46

7.4

4.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

567

1.31

1.46

1.5

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

2.50

1.45

1.0

1.3

—

(3034426) Prothrombin time (PT)

117

1.71

1.44

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

302

1.43

1.44

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

379

1.38

1.42

1.0

u/ml

0.1

0.4

1.22

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

448

0.67

1.42

1.4

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

126

1.67

1.40

2.0

2.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

231

1.48

1.36

1.9

1.4

e6/l

16997.7

67731.9

1.14

134

(3035880) pH of Pleural fluid

112

1.70

1.35

1.6

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

207

1.50

1.35

2.4

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

307

1.41

1.34

1.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.92

1.33

18.8

6.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.78

1.33

1.4

nmol/l

103.6

140.7

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

153

1.57

1.28

1.4

mmol/l

5.6

5.9

0.50

146

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.89

1.28

1.8

1.2

—

(4024509)

260

1.43

1.27

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

117

0.43

1.24

1.2

1.5

—

(40768806) Pleura Pathology biopsy report

236

1.44

1.24

1.4

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

2.22

1.24

1.3

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

1.86

1.23

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.86

1.23

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.86

1.23

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.86

1.23

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

782

1.23

1.20

1.3

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

479

1.30

1.20

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

657

1.25

1.19

2.5

2.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.31

1.18

3.3

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

125

1.60

1.17

2.0

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

125

1.60

1.17

2.0

2.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.93

1.17

1.4

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.50

1.15

1.6

1.3

mg/l

0.5

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.50

1.15

1.0

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

118

1.61

1.14

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

301

1.37

1.12

1.4

pmol/l

74.7

167.4

0.46

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.34

1.12

7.6

9.8

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

2.00

1.12

1.6

1.9

mg/l

2.0

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

458

1.29

1.12

1.3

1.4

—

(3024263) Appearance of Synovial fluid

159

1.51

1.11

2.3

1.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.26

1.10

2.1

2.6

u/field

0.4

0.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

160

1.50

1.09

1.4

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

160

1.50

1.09

1.4

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

2.12

1.05

1.0

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

113

1.60

1.05

1.2

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

121

1.57

1.05

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

212

1.42

1.03

1.8

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.96

1.03

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

402

1.30

1.03

1.3

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.06

1.02

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.06

1.02

1.1

1.2

umol/24h

1.9

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.84

1.02

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

138

1.52

1.02

2.6

3.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

114

1.58

1.02

2.4

2.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.92

1.02

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

316

1.33

1.01

1.0

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.00

1.00

1.0

1.2

—

619.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.84

0.98

1.0

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.2

—

6.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

579

1.23

0.93

4.6

3.6

mg/l

24.7

25.0

0.02

350

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.60

0.90

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.60

0.90

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

305

1.31

0.90

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.75

0.90

21.5

6.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.69

0.88

1.4

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.91

0.88

1.1

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

105

0.48

0.88

6.4

5.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

105

0.48

0.88

3.2

2.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.61

0.87

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.86

0.87

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.00

0.87

1.2

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

187

1.39

0.85

1.3

1.5

—

(4094501)

107

918

1.17

0.85

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

129

1.48

0.83

1.4

2.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.88

0.81

1.2

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

181

1.38

0.79

1.1

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

312

1.29

0.79

4.2

4.8

u/ml

15.6

82.7

1.96

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.67

0.78

1.0

1.2

—

77.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.53

0.78

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

174

0.63

0.76

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.52

0.75

1.3

1.5

—

(3045142) Bone marrow Pathology biopsy report

333

1.26

0.74

1.1

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

100

1.50

0.72

1.1

2.1

—

26499.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.00

0.72

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.80

0.72

1.6

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

183

0.65

0.72

1.2

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

194

1.34

0.71

1.1

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

186

1.35

0.70

1.0

u/ml

0.4

—

(40757373) Influenza virus identified in Isolate

1.55

0.69

1.2

1.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

239

1.30

0.69

2.2

2.6

e6/l

951.9

686.1

1.28

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.53

0.68

1.4

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

267

1.28

0.66

1.2

1.1

mg/l

34.2

42.9

1.31

221

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.79

0.66

1.8

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.79

0.66

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

200

0.70

0.62

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

252

1.27

0.62

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1080

0.88

0.61

1.4

—

(44813793)

217

1.29

0.61

1.0

1.1

—

(3012898) Urea [Moles/volume] in Urine

1.67

0.61

1.2

1.4

mmol/l

246.0

170.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.57

0.60

1.8

1.5

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.59

0.0

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.58

0.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

193

1.30

0.57

1.1

u/l

1.0

1.1

—

102

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.67

0.56

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.67

0.56

1.8

2.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.54

0.55

1.0

1.2

—

75.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.42

0.54

3.1

3.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

463

4860

0.95

0.53

1.4

—

(3004451) EKG impression Narrative

143

1.33

0.52

1.1

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.50

0.51

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

536

5132

1.05

0.50

2.8

2.7

ug/l

0.7

0.00

345

3107

(40761535) Cells panel - Urine sediment

251

2350

1.07

0.49

4.3

3.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.46

0.46

1.3

2.0

—

(40768800) Prostate Pathology biopsy report

494

0.85

0.46

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.45

0.44

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.56

0.42

2.4

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.56

0.42

2.0

2.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

5.9

—

468.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.39

0.40

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

1.34

0.39

1.2

1.1

—

(4027681)

205

1.22

0.39

1.4

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

160

1.25

0.38

1.3

1.8

—

8.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

533

1.13

0.38

2.7

3.6

u/ml

26.4

30.9

0.29

522

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

717

6967

1.04

0.37

3.9

3.7

22.7

21.4

1.22

271

3025

(3019174) dRVVT (LA screen)

1.35

0.37

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.35

0.37

12.2

10.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

125

1347

0.93

0.35

2.1

1.9

—

(3000285) Sodium [Moles/volume] in Blood

1.43

0.35

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.36

0.34

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.33

0.33

1.2

2.8

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

478

0.88

0.33

3.6

2.6

13.6

13.2

1.40

473

(3025130) Human papilloma virus identified in Specimen

406

1.13

0.33

1.2

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.30

0.33

1.2

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.35

0.31

1.3

2.1

mmol/l

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

0.71

0.30

1.1

1.3

51.8

50.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

147

1.23

0.30

1.7

2.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

184

1.20

0.30

10.5

6.7

u/ml

55.6

178.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

180

1899

0.95

0.30

1.5

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

259

0.85

0.28

1.3

1.4

ug/l

4.6

3.9

0.16

222

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

103

1.26

0.28

1.4

1.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

103

1.26

0.28

1.6

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

1.26

0.26

1.8

11.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

345

3567

0.96

0.26

8.6

6.3

—

(40768793) Breast Pathology biopsy report

695

1.08

0.24

1.3

—

(44806118)

350

1.12

0.24

1.2

1.5

—

(44790049)

350

1.12

0.24

1.2

1.5

—

(44790048)

350

1.12

0.24

1.2

1.5

—

(44790047)

350

1.12

0.24

1.2

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

558

0.91

0.23

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

558

0.91

0.23

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.28

0.23

3.0

3.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.28

0.23

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

4.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(40758358) Immune stain study

0.00

0.20

0.0

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

112

1178

0.95

0.19

2.0

1.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.20

0.19

7.8

7.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.18

0.19

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

175

0.86

0.18

2.0

2.1

ug/l

1.6

3.4

—

155

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.24

0.18

1.1

1.4

49.6

30.0

—

(3009871) Measles virus Ab [Titer] in Serum

128

1.17

0.18

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

205

0.88

0.17

1.0

ng/l

30.8

44.8

0.68

133

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

148

1.15

0.16

1.1

miu/ml

1544.6

1549.2

0.01

148

(3010144) Erythrocytes [#/volume] in Synovial fluid

282

1.10

0.16

1.4

e6/l

8392.7

51397.4

1.12

201

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

204

0.88

0.16

1.0

ng/l

227.9

316.1

0.83

137

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

225

1.11

0.16

1.2

1.3

—

(3020650) Glucose [Presence] in Urine

0.75

0.15

1.7

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

203

0.89

0.15

1.0

ng/l

911.5

767.6

0.65

133

(40765089) Chromosome analysis panel - Blood by G-banded

1.10

0.15

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

123

1.14

0.12

1.3

2.1

—

(3006270) Folate [Moles/volume] in Blood

239

1.09

0.12

1.1

nmol/l

378.8

388.5

0.07

216

(4034850)

103

998

1.03

0.10

13.6

8.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.04

0.09

1.6

2.1

—

(40758292) HTLV I+II Ab panel - Serum

1.07

0.08

1.2

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.78

0.08

1.4

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.14

0.08

1.0

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.06

0.07

1.0

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

167

1699

0.98

0.07

2.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.89

0.06

1.9

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

0.85

0.06

1.6

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

231

0.95

0.04

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

212

1.04

0.02

7.3

6.4

—

(3015183) Erythrocyte sedimentation rate

192

0.99

0.00

1.3

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

195

1.03

0.00

3.0

2.8

43.9

41.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

250

2497

1.00

0.00

1.7

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

6.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.89

0.00

1.8

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1308.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

129.9

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.85

0.00

1.0

1.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

0.8

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(4133840)

0.98

0.00

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.85

0.00

1.0

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.90

0.00

1.0

1.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

250

1.00

0.00

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

44.0

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

0.0

1.0

—

2.3

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

163.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

3.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

5.8

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

8.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.96

0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint NAFLD and mortality.

Females

Parameter	HR [95% CI]	p-value
NAFLD	2.01 [1.77, 2.28]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.127

During the follow-up period (1.1.1998 — 31.12.2019), 867 out of 7023 females with NAFLD died.

Males

Parameter	HR [95% CI]	p-value
NAFLD	2.179 [1.91, 2.48]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1066 out of 7507 males with NAFLD died.

Mortality risk

Mortality risk for people of age

years, who have NAFLD.

N-year risk	Females	Males
1	0.139%	0.401%
5	1.033%	2.268%
10	2.558%	5.635%
15	5.085%	10.176%
20	9.129%	16.963%

Relationships between endpoints

↥

Index endpoint: NAFLD – Nonalcoholic fatty liver disease

GWS hits: 5

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Nonalcoholic fatty liver disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints